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ABSTRACT OF THE DISSERTATION
ELECTROCHEMICAL IMMUNOSENSING OF CORTISOL IN AN AUTOMATED
MICROFLUIDIC SYSTEM TOWARDS POINT-OF-CARE APPLICATIONS
by
Abhay Vasudev
Florida International University, 2013
Miami, Florida
Professor Shekhar Bhansali, Major Professor
This dissertation describes the development of a label-free, electrochemical
immunosensing platform integrated into a low-cost microfluidic system for the sensitive,
selective and accurate detection of cortisol, a steroid hormone co-related with many
physiological disorders. Abnormal levels of cortisol is indicative of conditions such as
Cushing’s syndrome, Addison’s disease, adrenal insufficiencies and more recently posttraumatic stress disorder (PTSD). Electrochemical detection of immuno-complex
formation is utilized for the sensitive detection of Cortisol using Anti-Cortisol antibodies
immobilized on sensing electrodes. Electrochemical detection techniques such as cyclic
voltammetry (CV) and electrochemical impedance spectroscopy (EIS) have been utilized
for the characterization and sensing of the label-free detection of Cortisol. The utilization
of nanomaterial’s as the immobilizing matrix for Anti-cortisol antibodies that leads to
improved sensor response has been explored. A hybrid nano-composite of PolyanalineAg/AgO film has been fabricated onto Au substrate using electrophoretic deposition for
the preparation of electrochemical immunosening of cortisol. Using a conventional 3electrode electrochemical cell, a linear sensing range of 1pM to 1µM at a sensitivity of
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66µA/M and detection limit of 0.64pg/mL has been demonstrated for detection of
cortisol.

Alternately,

a

self-assembled

monolayer

(SAM)

of

dithiobis(succinimidylpropionte) (DTSP) has been fabricated for the modification of
sensing electrode to immobilize with Anti-Cortisol antibodies. To increase the sensitivity
at lower detection limit and to develop a point-of-care sensing platform, the DTSP-SAM
has been fabricated on micromachined interdigitated microelectrodes (µIDE). Detection
of cortisol is demonstrated at a sensitivity of 20.7µA/M and detection limit of 10pg/mL
for a linear sensing range of 10pM to 200nM using the µIDE’s.
A simple, low-cost microfluidic system is designed using low-temperature cofired ceramics (LTCC) technology for the integration of the electrochemical cortisol
immunosensor and automation of the immunoassay. For the first time, the non-specific
adsorption of analyte on LTCC has been characterized for microfluidic applications. The
design, fabrication technique and fluidic characterization of the immunoassay are
presented. The DTSP-SAM based electrochemical immunosensor on µIDE is integrated
into the LTCC microfluidic system and cortisol detection is achieved in the microfluidic
system in a fully automated assay. The fully automated microfluidic immunosensor hold
great promise for accurate, sensitive detection of cortisol in point-of-care applications.
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CHAPTER I
Introduction
1.1 Motivation
Cortisol, a steroid hormone, is a biomarker for numerous diseases and plays an
important role in the regulation of various physiological processes such as blood
pressure, glucose levels, and carbohydrate metabolism, within the physiological limit [1,
2]. Abnormal increase in cortisol levels inhibits inflammation, depresses immune system,
increases fatty and amino acid levels in blood. While excess cortisol levels have been
shown to contribute to the development of Cushing’s disease with the symptoms of
obesity, fatigue and bone fragility[3], decreased cortisol levels lead to Addison’s disease
which is manifested by weight loss, fatigue, and darkening of skin folds and scars[4].
There has been growing interest in measurement of cortisol to establish whether cortisol
variation can be used as a precursor to medically and psychologically relevant events
such as stress, the most recent affliction being post-traumatic stress disorder (PTSD)[57]. Since cortisol secretion is dependent on environmental and behavioral triggers,
measurement of cortisol at point-of-care has become imperative to understand behavioral
patterns. Furthermore, normal levels of cortisol secretion follow a circadian rhythm with
cortisol levels highest during daybreak and progressively lower as the day progresses[1].
Currently, in clinical practice, total cortisol, which is the sum of free and protein
bound fractions, is measured. However, free cortisol is the only biologically active
fraction [8]and is responsible for all cortisol related activities in the body. Hence, in order
to diagnose and properly treat cortisol-related conditions, regular estimation of free
cortisol is required. Most current strategies for estimation of free cortisol are limited to
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laboratory techniques that are laborious, time-consuming, require large sample volume,
expensive, and cannot be implemented at point of care [9-15]. Another significant
shortcoming of the current set-up is that they only provide a snapshot of the cortisol
levels of samples submitted in a diagnostic lab and do not provide a true representation of
the cortisol variations that a specimen undergoes in an environment that triggers cortisol
generation or suppression. Hence, real-time and continuous monitoring of cortisol levels
is required to obtain valuable information that could assist doctors in better diagnosis and
treatment of cortisol related conditions. Detection of 24-hour cortisol levels is currently a
cumbersome process, which either involves admitting the patient for the time of
study[16] or where the patient samples blood/saliva into vials at specified time intervals
during the 24-hour time period, and ships it to a diagnostic laboratory[17]. The typical
turnaround time is 8 to 10 days and is still not a true representation of cortisol levels in
stressful environments. Hence there is a need to develop sensing strategies for the
detection of cortisol for application at point-of-care. Application at point-of-care requires
that the sensor be portable, have a miniaturized form factor, disposable, sterile, low
power consumption, have low turnaround time and is cost effective[18-20]. The
motivation for this dissertation is to explore strategies to develop cost-effective,
disposable, miniaturized sensors for detection of cortisol at point-of-care. The approach is
based

on

developing

single-use,

disposable

nanostructured

electrochemical

immunosensors for the detection of cortisol and integrating it into a microfluidic system
for automation of the immunosensing assay.

2

1. 2 Specific Aims
Specific Aim 1: Electrophoretically deposited Polyanaline-Ag/AgO hybrid nanocomposite
based electrochemical immunosensor for mediator free detection of cortisol
The first activity that will be undertaken in this dissertation is to develop a sensing
platform for the detection of cortisol. Electrochemical immunosensing in an
electrochemical cell set-up will be used for the detection of cortisol in a label-free
manner. To increase the electro-active surface area for higher loading of cortisol
antibodies and mediator free electrochemical detection of cortisol, a nanostructured
matrix

of

electrophoretically

deposited

Polyanaline

(PANI)-Ag/AgO

hybrid

nanocomposite will be used as the matrix for immobilizing anti-cortisol antibodies on the
working electrode. This task also involves the optimization of the electrophoretic
deposition process and electrochemical characterization of the bio-functionalization of
the electrode. Electrochemical response studies of immunoelectrode as a function of
cortisol concentrations will also be undertaken to determine the sensitivity, detection
limit and linear sensing range.

Specific Aim 2: Dithiobis (succinimidyl propionate) (DTSP) self-assembled monolayer
(SAM) based electrochemical immunosensing platform for the detection of cortisol
Alternate to PANI-Ag/AgO as the nanostructured matrix, a self-assembled
monolayer based approach will be explored, where DTSP will be utilized as the
nanostructured matrix for immobilizing the Anti-cortisol antibodies onto the electrode
surface. To increase the sensitivity of detection and as a step towards a point-of-care
detection, microfabricated interdigitated microelectrodes (μIDE) will be utilized. The
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electrochemical characterization of DTSP and the electrochemical characterization of the
bio-functionalization of the interdigitated microelectrodes using DTSP will be studied.
Electrochemical response studies of immunoelectrode will be studied as a function of
cortisol concentrations. Experimental validation of the sensor results using ELISA to
determine sensor accuracy will be conducted.

Specific Aim 3:
Low Temperature Co-fired Ceramic (LTCC) based microfluidic system for integration
with electrochemical immunosensor for assay automation
To automate the electrochemical immunosensing assay, a microfluidic system will be
developed. As an alternative to silicon and polymer materials, the use of low temperature
co-fired ceramics (LTCC) will be explored for the fabrication of a simple, cost-effective
microfluidic system. To optimize the fluidic routine involved in the immunoassay,
computational fluid dynamic (CFD) will be utilized to optimize the design of the
microfluidic system geometry. Fabrication of the designed microfluidic system using
LTCC and its integration with the electrochemical immunosensor will be conducted.
System integration through addition of micro-valves, micro-pumps and microPotentiostat with the microfluidic system will be undertaken.
Non-Specific Adsorption (NSA) of Cortisol on LTCC
For the first time, a study will be conducted to determine the biocompatibility of
LTCC material in terms of non-specific adsorption on cortisol on LTCC to assess the
efficacy to develop LTCC based microfluidic system for immunoassay-based biosensors.
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1.3 Outline
In this dissertation, the development of a LTCC microfluidics based, disposable,
cost effective, electrochemical immunosensing system is presented. In Chapter I, the
motivation of the work and the specific aims are presented. In the first part of Chapter II,
a comprehensive literature review on the physiology of cortisol and the state of the art in
cortisol detection is presented. The 2nd part of Chapter II reviews the fundamentals of
microfluidics, the state of the art in microfluidic device development and a complete
overview of microfluidic device fabrication using Low Temperature Co-fired Ceramics
(LTCC) technology. Chapter III presents the details of the design, fabrication and testing
of the immunosensing platform for cortisol detection. The synthesis of a PolyanalineAg/AgO hybrid nanocomposite on the working electrode for immobilization of the anti-

cortisol antibodies and the detection of cortisol is presented. In Chapter IV, the design,
synthesis and testing of the Dithiobis (succinimidyl propionate) (DTSP) self-assembled
monolayer (SAM) based electrochemical immunosensing platform for the detection of
cortisol is presented. Fabrication of interdigitated microelectrode is also presented in
Chapter IV. Chapter V presents the design optimization, fabrication process, flow
characterization and automation of the LTCC microfluidic manifold for integration with
the electrochemical immunosensor chip. The summary of the research work undertaken,
concluding remarks and the future prospects are discussed in Chapter VI.
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CHAPTER
R II
Liiterature Reeview
2. 1 Cortisol
Cortissol is a one of the important glucoccorticoids (a family of stteroid hormones)
prroduced by the adrenal glands. Corttisol is smalll molecular weight (3622.46 grams/m
mole)
hormone, giv
ven by the chemical fo
ormula (11ββ)-11,17,21-ttrihydroxypregn-4-ene--3,20dione.
di
Fig. 1 presents thee chemical sttructure and the 3D arranngement of tthe atoms.

Fig 2.1 Chemical
C
stru
ucture of corrtisol; (a) 2D
D and (b) 3D
D
Cortissol plays mu
ultiple roles in human pphysiology, including m
maintaining bblood
glucose leveels, blood pressure
p
reg
gulation, annd homeosttasis of thee cardiovasccular,
im
mmune, skelletal and end
docrine systeem. Cortisoll levels flucttuate throughh a 24 hour cycle
caalled the cirrcadian rhytthm (Fig. 2),
2 highest vvalues 30 m
minutes afterr awakeningg and
grradually tap
pers down to
o a minimum
m during niight sleep[1]. Other conntrollable faactors
allso affect cortisol
c
leveels such as eating pattterns and pphysical acttivity. The most
dominating effect on corttisol variatio
on comes froom psychological/emotioonal stress, w
which
ol is popularrly called thee “Stress-horrmone”[2].
iss why cortiso
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Fig 2.2 The typicaal diurnal vaariation of coortisol levelss over a 24 hhour cycle.
The effects of abn
normal cortissol variationns for prolonnged periods of time refleect in
th
he disruption
n of the hom
meostasis in
n physiologiical processees. Cushing’s syndromee is a
ty
ypical exam
mple of hypeer-cortisol seecretion, whhere the affe
fected indiviidual experieences
seever weightt gain, supp
pressed imm
mune system
m, osteoporrosis, diabettes mellituss and
seeveral other negative efffects[3]. Ad
ddison’s dissease, whichh is a condittion arising from
hy
ypo-cortisollism, resultss in low blood
b
presssures, hypooglycemia, convulsions and
prrolonged fev
ver[4].
2.1.1 Secretio
on of Cortissol
Cortissol is a horm
mone that is secreted froom the adrennal glands located abovve the
kidneys. Corttisol is the end
e product of the Hypoothalamic-Pituitary-Adrrenal (HPA) axis,
which
w
is the main
m compo
onent of the human
h
bodyy’s adaptive system to m
maintain reguulated
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physiological processes under changing environmental factors. As the name suggests, the
HPA axis is a complex signaling system between the hypothalamus in the brain, the
pituitary glands and the adrenal glands. Fig. 3 presents a schematic of the HPA axis in
which a typical response to an environmental trigger is initiated by the hypothalamus that
releases a hormone called the CRH (Corticotrophin Releasing Hormone) that travels to
the pituitary glands. Specialized cells that work synergistically with the pituitary glands,
release ACTH (Adrenocorticotrophic Hormone) into the blood stream that travels to the
adrenal cortex. The adrenal cortex responds by increasing the production of cortisol.
Since the adrenal glands have no visible innervation, it can be inferred that ACTH is the
sole stimulant for initiating cortisol production. The adrenal glands do not store cortisol,
but they are prevalent in the form of precursors. Cholesterol undergoes multiple catalyzed
oxidation reactions to result in the formation of cortisol. This entire process takes place in
a time space of few minutes. The HPA axis is a negative feedback system, where Cortisol
plays a critical rule in the homeostasis of the HPA axis. Moderate homeostatic alterations
in the HPA axis is beneficial for the physiological and psychological development of the
human body, sustained and prolonged exposure to environmental triggers such as stress
leads to abnormal levels of cortisol in the circulatory system.
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Fig 2.3 Cortisol secretion regulated by the HPA axis
2.1.2 Source of Sample
Secreted cortisol finds its way into the circulatory system and can be found in detectable
quantities in several biofluids. In this section, an assessment of the advantages and
disadvantages of using various biofluids such as urine, blood, sweat, interstitial fluid
(ISF) and saliva for the detection of cortisol is presented.
2.1.2.1 Urine
Cortisol level in urine is measured over a 24-hour period and is referred to as the
24-hour Urinary free cortisol (UFC) test. Only free cortisol, which is the active form of
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cortisol in the human body, is found in urine and is hence a relevant biofluids for the
detection of cortisol. The excretion of hormones, salts and other waste chemicals through
urine is a well-characterized process with good knowledge about the concentration of
these waste substances under normal function. Observation of drastic variation in
concentrations of hormones such as cortisol can be used to diagnose abnormalities in the
adrenal function. Measurement of cortisol in urine typically requires the collection of all
the urine generated over a 24 hour time period. Normal range for cortisol in urine is 10 to
100 μg/24hrs. A review of the reported literature for urinary cortisol assays has been
presented by Brossaud et. Al. [5]
While the 24-hour urinary free cortisol test provides a means for a non-invasive,
painless method of obtaining body fluid for cortisol measurement, it also poses several
drawbacks with respect to convenience and reliability. Since the collection of the urine is
spanned over a 24 hour time period, sample collection becomes an inconvenient process
where the patient needs to carry the special urine collection container all day long or has
to remain confined to a location for the 24-hour period. The container also needs to be
stored under refrigeration from the time of collection till it is delivered to a diagnostic lab
for testing. Also, several factors such as pregnancy and medication such as diuretics can
alter the concentration of cortisol in urine making it a lesser reliable biofluids for cortisol
detection. These are several additional factors have severely limited the use of urine to
cases where patients are admitted to the hospital for long-term treatments. The
requirement of 24 hour sample collection has rendered urine unfit for real time detection
at point of care.
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2.1.2.2 Interstitial Fluid (ISF)
ISF is an extra cellular fluid that surrounds the cells in the human body. In composition,
it is similar to blood plasma. Metabolites and proteins move into ISF as they move from
capillaries to cells. In general, small to moderate sized molecules, including glucose,
ethanol, and cortisol are found in ISF in similar proportion as in blood. Thus, periodic
calibration using blood sampling is not required to obtain the concentration of these
metabolites from ISF. ISF is present just below the skin, but the low permeability of the
epidermal keratinized layer (the stratum corneum) blocks the permeation of the fluid
through the skin. However, obtaining ISF for detection of a target biomarker could
require an invasive approach as it is not readily accessible. Several approaches have been
reported in literature to obtain ISF in a minimally invasive, painless process. Venugopal
et. Al. [6] have reported the construction of an ISF harvesting system that utilizes a lowenergy laser to create micropores in the stratum corneum (the uppermost layer of dead
cells) (Fig. 4). The diameter of the micropores is approximately equal to that of a human
hair. The micropores only penetrate the stratum corneum and, hence, this procedure is
essentially painless. ISF is drawn through these micropores continuously by application
of a small amount of vacuum pressure. Harvesting of ISF using this set-up is reported at a
rate of 10µl/hr.
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Fig 2.4 (a) Crross-section of microporre generated through laseer ablation; ((b) Four porres
reelative to thee size of a peenny; (c) Han
ndheld laserr source usedd to create m
micropores.
Couplled with an
n electrochem
mical detecttion system
m, Bhansali et. Al. [7] have
reeported the detection
d
of cortisol usin
ng the same micro porattion set-up. Cortisol levels in
IS
SF were foun
nd to be 3 – 4 times larg
ger than thatt in saliva, w
which makes ISF an attraactive
biofluid for detection
d
of cortisol.
c
While this set-uup may proviide a means to access IS
SF for
co
ortisol detecction, the lo
ow harvestin
ng rate (100µl/hr) woulld limit its applicabilityy for
ob
btaining insttantaneous cortisol
c
valuees in a point of care settiing.
Micro
omachined microneedles
m
s for transdeermal appliccation are aanother optioon to
harvest ISF[8, 9]. Micrroneedles have
h
been uused extenssively for ttransdermal drug
delivery[9, 10
0]. Smith ett. al. [11] haave reportedd the design,, fabricationn and testingg of a
hollow micro
oneedle array
y containing fluidic micrrochannels ffor the transddermal extraaction
n. Wang et al.[12] hav e also reporrted the fabbrication of glass
of ISF from human skin
microneedles
m
for ISF extrraction for glucose
g
monnitoring. Theese approachhes show proomise
fo
or creating painless,
p
miinimally inv
vasive methoods for extrraction of IS
SF. Microneeedles
based transdeermal ISF extraction
e
may
m find goood applicattion in weaarable biosennsing
sy
ystem, wherre there is a critical
c
need
d to continuoously samplee body fluidss such as ISF
F at a
lo
ow sampling
g rate. Howeever, concern
ns regardingg biocompattibility and bbiodegradation of
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the microneedles, protection from infection due to usage of needles and other sterility
issues will need to be carefully addressed for successful implementation.
2.1.2.3 Hair
The use of hair as the biological sample for analysis and testing in forensic
sciences, toxological science, doping control and clinical diagnostics has gained
considerable attention over the last two decades [13]. Human hair grows at a predictable
rate of approximately 1 cm/month. Cortisol is known to deposit in the shaft of the hair
and the most proximal 1 cm segment of hair closest to the scalp approximates the last
month’s cortisol production and so on. The mechanism for the incorporation of cortisol
into the hair shaft has been proposed by Bennett et. Al. [13]. Fig. 5 presents an
illustration of cortisol storage mechanism in the hair follicle and its usage for analysis of
long-term exposure of cortisol. Cortisol is thought to enter hair primarily at the level of
the medulla of the hair shaft via passive diffusion from blood. In this scenario hair
cortisol would be hypothesized to reflect the integrated free cortisol fraction rather than
the total cortisol concentration in serum.
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Fig 2.5 Schem
matic illustraation of the accumulation
a
n of cortisoll in the meduulla of a hairr
fo
ollicle.
One of
o the first sttudies to esttablish feasibbility of usinng hair for ccortisol deteection
was
w reported by Koren ett al.[14] usin
ng hair from
m wild hyraxxes. Detectioon was perfoormed
using a modiified salivary
y ELISA prrotocol. Sauvve et al. [155] reported tthe first studdy on
uman hair samples
s
for cortisol dettection and reported a reference raange from 11.7 to
hu
153.2 pg/mg.. The obtain
ned values were
w
comparred to those obtained froom saliva, sserum
an
nd 24-hour urine. A po
ositive correlation was iidentified onnly to that oof 24-hour uurine,
with
w no correelation to thaat of saliva or
o serum. Haair cortisol m
measuremennt surely proovides
a non-invasiv
ve method off obtaining a biological sample. Sinnce the cortisol concentrration
in
n hair is hy
ypothesized to represen
nt long-term system expposure, it ccould be useed as
in
ndexing metthod to maaintain a co
ortisol secreetion calenddar. From thhe various other
reeported studies [16-22] for
f cortisol detection
d
froom human hhair, it is eviident that coortisol
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values only for long-term exposure to factors such as stress can be obtained. The
resolution of the data obtained is in the order of months, with very little clinical data
available to support the correlation of hair cortisol levels to stress levels.
2.1.2.4 Sweat
Sweat analysis is a well-established method for diagnosis certain conditions such as
cystic fibrosis and drug abuse. Sweat patches could be used as effective non-invasive
tools to collect biofluids[23]. Cortisol in sweat has been measured by Russell et al[24]
with cortisol concentrations ranging from 141.7 ng/mL (daytime) to 8.16 ng/mL. It is
hypothesized that there exists a strong correlation between cortisol levels in sweat and
hair due the path that cortisol traverses from serum, sebum and sweat to the hair.
However, very little is known about cortisol in sweat and several inherent drawbacks
exist in obtaining reliable and repeatable sweat samples to accurately measure cortisol in
sweat. Perspiration is dependent on several factors such as weather conditions (humidity,
temperature), geographic conditions, physical activity levels, ambient temperature or
conditioned temperature and genetic make of the patient.
2.1.2.5 Blood
More than 90% of cortisol in blood is in an inactive state being bound to corticosteroid
binding globulin (CBG) and serum albumin. Only 10% of total cortisol is in a
biologically active state to participate in cortisol initiated processes. Typically assays for
measuring cortisol in blood involves measuring the total cortisol (bound + free) and then
the active fraction, called the Cortisol Free Index (CFI) is deduced using the Coolen’s
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equation[25]. Blood sampling for cortisol detection has been the oldest form of biofluid
sampling. The nominal value for cortisol in blood varies from 25µg/dL (9AM) to 2µg/dL
(midnight). Blood however is afflicted by many drawbacks, which has made it a last
choice sampling fluid. Sampling blood requires attention from medical staff and
specialized, sterile equipment with an ever-existing concern for infections. While cortisol
is a stable molecule at room temperature, its presence in plasma requires special handling
and storage condition as it is considered a biohazard. Since sampling blood requires
puncture of veins, a painful procedure, the stress experienced by patients prior to and
during sampling may elevate cortisol levels[26]. Although the typical response time for
cortisol spiking is 10 to 15 minutes in humans, prior knowledge of venipuncture can
initiate the stress response induced cortisol spiking. Also, the costs associated with staff,
equipment, handling and storage makes blood based assay a shunned option.
2.1.2.6 Saliva
Over the last few years, saliva has gained considerable attention as a biofluid for analysis
and detection of cortisol concentrations. This has come about mainly due to inherent
advantages associated with saliva. First and foremost, a well-documented and studied
strong correlation exists between salivary and blood cortisol levels[27, 28]. Also, of high
importance is the fact that cortisol in saliva exists entirely in the free state in saliva unlike
in blood (90% bound), resulting in detection of the relevant (biologically active) form of
cortisol. This is mainly due to the filtering of the CBG and Albumin bound cortisol
during capillary exchange and other intracellular mechanisms at the salivary ducts.
Harvesting samples for analysis is almost completely non-invasive with little or no
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discomfort to the specimen providing the sample[29]. The last few years has seen the
establishment of standard operation procedures for collection of saliva, which has led to
lesser variability in analyzed results. The samples can be harvested with minimum efforts
that have facilitated patients to collect their own samples at home. Cortisol remains stable
in saliva at room temperature, resulting in reduced costs and efforts in sample handling
and storage. All these advantages of salivary techniques have led to saliva being on the
verge of becoming the preferred source of body fluid for detection of cortisol. However,
there are certain aspects that may adversely affect the prospects of saliva based cortisol
detection. Since only the active component of cortisol (free cortisol) is present in saliva,
the concentration of cortisol is much lower than that of blood. The nominal values for
cortisol in saliva during the diurnal cycle varies from 0.5µg/dL to 0.05 µg/dL, which
requires high sensitivity assays with low detection limits for efficient detection of cortisol
concentration in saliva. A strict compliance to the standard operating procedure for
saliva collection can lead to erroneous results. Sometimes, presence of blood due to oral
leasons may lead to elevated levels of cortisol and cause erroneous results. Salivary
cortisol assays have been reported in literature extensively for characterizing the
circadian rhythm[30], Cushing’s syndrome[31], Addison’s disease[32], adrenal
abnormalities[33] and stress related disorders[34].
The overwhelming advantages of using saliva as a biofluid for biomarker
detection has made it the preferred method. Also, the ease of sample collection, handling
and storage has heightened the prospects of applying point of care sensors for real-time
and continuous detection of cortisol. For these reasons, this research undertakes the
development and characterization of salivary assays for electrochemical immunosensing
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of cortisol and its application of point-of-care through incorporating into an automated
microfluidic system.
2.1.3 Detection of Cortisol: State of the art
Having studied the physiology of cortisol and evaluating the pros and cons of the
different sources of biofluids for cortisol detection, this section provides a comprehensive
overview of the various detection techniques for quantification of cortisol.
2.1.3.1 High Performance Liquid Chromatography (HPLC)
HPLC is the older and one of the first techniques to detect cortisol.

HPLC is a

chromatographic technique that used high pressure (50 to 350 bar) to separate a mixture
of compounds using a process of mass transfer induced adsorption. While RIA was used
to determine cortisol in serum, HPLC was used to determine cortisol concentrations in
saliva. HPLC lacks the specificity that is required in measuring low concentrations, as the
technique is severely affected by interference from co-eluting substances in the sample.
HPLC also requires many preprocessing procedures such as solid-phase extraction[35].
2.1.3.2 Immunoassays
Immunoassays are based on the ability of an antibody to recognize and selectively bind to
an antigen, referred to as the analyte. The high degree of selectivity and specificity of an
antigen-antibody binding makes immunoassays the gold standard technique for detection
of presence, and measurement of the concentration of the analyte of interest. After
successfully capturing the analyte, traditional process of immunoassays employ a label to
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detect the analyte. Enzymes, fluorescent tags and radioisotopes are some of the
commonly used labels. Immunoassays may be performed in different configurations,
depending on the analyte, label and detection technique. The primary classification of
immunoassays is based on washing (heterogeneous) and no-washing (homogenous) of
the sensing substrate after sample incubation. While homogenous immunoassays involve
lesser assay steps, its application is limited by sensitivity and noise arising from nonspecific interactions. Heterogeneous immunoassays are further classified based on
competitive/noncompetitive and labeled/unlabeled binding of the antigen to the antibody
(Fig. 6). In a competitive immunoassay, the analyte of interest (unlabeled) competes with
a known concentration of labeled analyte of the same kind. At the completion of the
reaction, the concentration of the unbound, labeled analyte is measured, from which the
concentration of the analyte of interest is deduced (Fig. 6a). Accordingly, in a
noncompetitive immunoassay, only the analyte of interest is allowed to freely bind to the
antibodies and a then the analyte is labeled to measure the concentration (Fig. 6b). To
increase the sensitivity and selectivity of the immunoassay, a two-site or sandwich
immunoassay is performed, where two a pair of antibodies are used, one for capturing the
analyte and the other for detection (Fig. 6c).
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Fiig 2.6 Schem
matic illustraations of variious immunooassay technniques
Several transducttion techniq
ques have bbeen developped to obtaain a measuurable
siignal that is proportional to the conccentration off the captureed analyte annd can be brooadly
cllassified as optical and electrical. For
F detectioon of cortisool, radioimm
munoassay (R
RIA),
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which involves the use of radioisotopes as label was reported in the late 1970’s [36-40].
Since the 1980’s use of RIA has diminished due to the potential harmful effects of
handling radioisotopes. The focus has shifted towards the use of labels with fluorescing
property. The use of fluorescent tags such as fluorescein isothiocyanate (FITC) [41],
mixture of sulfuric acid and acetic acid[42] have been used as the label in cortisol
immunoassays. A fluorescence detector is utilized to read the intensity of fluorescence,
which is proportional to the concentration of the fluorescence labeled analyte. Another
popular optical based immunoassay is the electrochemilumenescence immunoassay
(ECLIA). ECLIA is based on the electrogenerated chemilumenescing property of
intermediates undergoing a highly exergonic reaction to produce an electronically excited
state that emits light. ECLIA has developed into highly reliable immunoassay technique
due to the high sensitivity and precise control over the electrochemical reaction. ECLIA
has found application in many clinical studies for cortisol detection in human samples for
Cushing’s syndrome[43, 44],

obesity[45], athletic disorders [46] and stress related

disorders such as PTSD[47, 48]. Of all the available labeled immunoassays, Enzyme
Linked Immunosorbent Assay (ELISA) is the most sensitive and versatile and is today
considered the gold standard in protein concentration determination. ELISA is typically
performed in a sandwich format, where an enzymatic substrate is added to the secondary
antibody to amplify the colorimetric or fluorescent signal, thereby providing a high
sensitivity. Detection of cortisol using ELISA is used widely [49, 50] has often been the
technique used to validate results obtained from newer techniques being developed for
cortisol detection [51]. ELISA kits for detection of various analytes are commercially
available now. While this method is the most widely used technique in research labs and

23

industry, the method is limited by the need for large sample and reagent volumes and
complexity arising from multiple assay steps and large incubation times.
To overcome the tedious processes, cost and shortcomings of the assay
performance, focus has shifted towards developing label-free immunosensing techniques
with high sensitivity, lower detection limits and broader detection range[52]. One such
technique that demonstrates label-free detection is based on Surface Plasma Resonance
(SPR)[53]. SPR works on the principle of oscillation of valence electrons in a conducting
substrate irradiated with light. SPR is highly sensitive to adsorption of molecules onto the
substrate, where the resonance curves shift to higher angles with adsorption of molecules
onto the surface. SPR has shown promise as a method to quantitatively measure the
capture of analyte on substrates coated with anti-bodies. The associated detection optics
and electronic for SPR measurement can be reduced to miniaturized form factors and has
hence attracted efforts to create point-of-care immunosensors[54]. More recently,
detection of cortisol in saliva[55] and other biofluids using SPR has been reported in
literature. On the same lines as SPR, another technique gaining ground for
immunosensing is based on the resonance property of quartz crystal microbalance
(QCM)[56].
2.1.3.3 Electrochemical Immunosensing
Since the focus of this dissertation is on developing strategies for cortisol
detection based on electrochemical immunosensing, this topic is discussed elaborately.
Among the label-free technologies for detection in immunosensing, electrochemical
immunosensing has emerged as the most promising alternative to optical detection.
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Electrochemical immunosensing is based on the principle of measuring the changes in
electrical properties of a conductive material due to the adsorption of an analyte on the
surface functionalized with antibodies. The electrical change is attributed to the change in
the concentration of the electro active redox species at the electrode proximity. The
mature processing capability of the microelectronics industry has allowed building
microelectrodes that provide high sensitivity and very low detection limits. The
simplicity of electronic circuitry for electrochemical detection and cheap volume
manufacturing has driven efforts to bring electrochemical immunosensing up to speed
with

other

immunosensing

techniques.

The

elementary

requirement

for

an

electrochemical immunosensor is a conductive substrate, which permits the
immobilization of antibodies. Metals such as Au, Ag and Platinum and carbon electrodes
intrinsically allow adsorption of antibodies, but the resulting binding is not robust and
stable enough. To overcome this problem and to improve the electrochemical response,
nanomaterials are employed as a linker molecule between the electrode surface and the
antibodies. The choice of material is dependent upon the formation of bond with the
conducting electrode surface and the presence of functional groups on the nanomaterial
for covalent binding to antibodies. A detailed discussion on nanomaterial’s for
electrochemical biosensing is presented in a later part in this chapter.
Many strategies for sensing the immuno-reaction exist and is represented in Fig.
7. The traditional sandwich immunoassay may be utilized, in which, the secondary
antibody is an antibody-enzyme conjugate, and the added enzyme substrate produces an
electro active product that can be measured at the electrode surface (Fig. 7a). A simpler
and efficient strategy, called the direct assay, involves measurement of the change in
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ellectro activiity of the ellectrode duee to reducedd electro acttive probes arising from
m the
sp
patial blockiing of the electrode surrface area byy the adsorpption of the captured annalyte
(F
Fig. 7b). Thiis technique,, though sim
mple, may som
metimes lead to false poositive resultts due
to
o non-specifi
fic adsorption
n and hence effective chhemical strattegies need to be employyed to
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vercome non
n-specific ad
dsorption.

Fig. 2.
2 7 Schemattic of strateg
gies used forr electrochem
mical immunnosensing
All electrochemiccal reactions are governeed at least inn part by the Nernst equaation,
which
w
fundam
mentally deffines the rellationship beetween the ppotential at an electrodee and
th
he concentraations of tw
wo redox sp
pecies (oxidiized and reeduced) invoolved in a rredox
reeaction. The redox reactiion and the Nernst
N
equattion are reprresented as:
O + (n) e- ↔ R
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Eo is the redox potential for the coupling involved in the oxidation and reduction,
CO is the concentration of the oxidized species, CR is the concentration of the reduced
species, R is the universal gas constant (8.3144 J K-1 mol-1), T is the absolute temperature,
n is number of moles of electrons transferred in the cell reaction, F is Faraday constant
(9.648 x 104 C mol-1).
Based on the electrical property being measured, electrochemical sensors can be
classified

as

Potentiometric,

Voltammetric

and

Impedimetric.

Potentiometric

immunosensors passively measure the potential between two electrodes. The set-up
consists of an electrode pair, where the potential on one electrode is maintained constant
(reference) and the potential at the other electrode (immunoelectrode) is measured with
respect to the reference electrode. The immunoelectrode usually uses electrodes that have
been made ion selective. The measured potential can then be correlated to the
concentration of the analyte directly from the Nernst equation. Potentiometric
immunosensing is not a popular strategy due lack of sensitivity, accuracy, precision and
stability[57]. This is due to a basic assumption that the measured potential accurately
reflects the equilibrium position of an electrochemical reaction, which is often not the
case. The interference arising from the sample matrix will supersede the signal arising the
specific binding of an analyte. Voltammetric techniques involve the application of a
constant potential to the immunoelectrode surface and measuring the resulting steady
state current generated by the electroactive redox species. It may be noted that the
difference between voltammetry and amperommetry is trivial and confusion in literature
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is due to the introduction of scanning techniques in voltammetry, where the potential is
help for a brief length of time (for current measurement) and then increased/decreased for
further measurements. Voltammetric techniques can be described as a function of
Voltage, Current and Time. Linear sweep voltammetry (LSV), the potential at the
working electrode (immunoelectrode) is swept at a specific rate (volts/sec) from a lower
potential to a higher potential, and the current at each potential step is measured[58]. A
variant to this technique, called cyclic voltammetry (CV) entails applying a triangle
potential waveform from an initial value to a predetermined upper limit, where the
direction of the sweep is reversed[59]. As the potential is swept back and forth, the
current on the working electrode is observed. Analysis of the current response can be
used to study the thermodynamics and kinetics of electron transfer at the electrodesolution interface. Moreover it helps to study the kinetics and mechanism of solution
chemical reactions initiated by the heterogeneous electron transfer. Cyclic voltammetry
can also be described as an analytical tool by which information about the analyte can be
obtained by measuring the current flowing on the working electrode that either oxidizes
or reduces the analyte. The magnitude of this current is proportional to the concentration
of the analyte in solution, which allows cyclic voltammetry to be used in determination of
the analyte concentration. The current at the working electrode (faradaic current) can be
plotted as a function of time or since the potential is linearly related with time, as a
function of voltage. The representation of the response in cyclic voltammetry experiment
is usually the current-potential curve, which is called “cyclic voltammogram” (Fig. 8).
As the potential is swept in the forward direction, a cathodic peak is observed.
Reduction occurs in this positive scan and the current resulting from the reduction is
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caalled cathod
dic peak currrent. The po
otential valuee in this poiint is called as cathodic peak
potential. Thee representaations of theese terms aree ipc and Eppc respectiveely. Note thaat the
reeduction currrent is taken
n as positive as the cathoodic sweep ggoes from leeft to right. A
At the
sw
witching pottential, the direction
d
of the potentiaal sweep is rreversed. In the reverse scan,
ox
xidation occcurs and a peak
p
resultin
ng from the oxidation pprocess is caalled anodic peak
cu
urrent. A negative anodiic peak curreent is observved in the caase of oxidattion processs. The
reepresentation
ns for the anodic
a
peak current andd anodic peeak potentiall are ipa andd Epa
reespectively. A typical cy
yclic voltamm
mogram is ggiven in Fig. 8 with a cleear representtation
of the defined
d characterisstics such as ipc, Epc, ipa aand Epa.

Fig
g. 2.8 A typiical cyclic vo
oltammograam with definned characteeristics
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The Randles - Sevick equation[60] can be used to predict the concentration of the
redox species from the peak current obtained in a CV for a reversible redox reaction.
= (2.69 x 105 )

3/2

1/2

1/2

Where ip is the peak current (in amperes), n is the number of electrons passed per
molecule of analyte oxidized or reduced, A is the electrode area (in cm2), D is the
diffusion coefficient of analyte (in cm2/sec), ν is the potential sweep rate (in volts/sec),
and C is the concentration of analyte in bulk solution (in moles/cm3). Bhansali et al at the
bio-MEMS and Microsystems research group at Florida International University have
reported the development of electrochemical immunosensing of cortisol based on cyclic
voltammetry[61-63]. A competitive electrochemical immunosensor for detection of
cortisol and ACTH has also been reported[64].
Lastly, a review of Electrochemical Impedance Spectroscopy (EIS), an
impedimetric electrochemical technique for immunosensing is presented. EIS is a highly
sensitive technique for probing the features of surface modifications at the electrodeelectrolyte interface[65]. EIS can be used to detect the formation of an antigen-antibody
immunocomplex through the highly sensitive change in the resistance (faradaic) and
capacitance (non-faradaic) at the electrode surface[66]. The faradaic component arises
from the electron transfer at the electrode-electrolyte interface by overcoming an
activation barrier called the polarization resistance (Rp) along with an intrinsic solution
resistance (Rs). The non-faradaic component arises from the formation of a double layer
capacitor on the electrode surface. By sweeping the frequency of the applied voltage,
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frrequency deependent beehavior of the
t faradaicc and non-ffaradaic com
mponents caan be
cllearly disting
guished. Thee measured impedance iis the sum oof the real paart and imagginary
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(F
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d the Randlles circuit (Fig.
(
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parameter off interest. Seeveral reseaarch groups are currenttly focusingg their efforrts on
developing EIS
E based detection
d
fo
or immunoseensing of E
E. Coli[67],, cytokines [68],
virus[69] and
d other cliniically relevaant biomarkeers[70, 71]. Bhansali ett al. are thee first
reesearch grou
up to detect cortisol
c
in a label-free m
manner usingg electrocheemical impeddance
sp
pectroscopy [7, 72, 73].
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Fig
F 2.9 Electrrochemical impedance
i
spectroscopy
s
y data represented in term
ms of (a) Nyyquist
plott and (b) Bodde plot.

2.1.3.3.1 Nan
nomaterials
In thee last decade nanostructu
ured materialls have expeerienced a raapid developpment
du
ue to their potential
p
app
plications in
n a wide varriety of technnologies succh as electroonics,
caatalysis, ceraamics, magn
netic data sto
orage, structuural componnents, optoellectronic devvices,
display devicces, biomateerials and gaas/bio sensorrs [74, 75]. Such materrials have shhown
peculiar and
d fascinating
g chemical,, physical and molecuular properrties along with
ap
pplications performancce superior to those of their buulk counterrparts [75]. For
ellectrochemiccal detection
n, nanomaterrial’s play a very importtant role since they influuence
alll aspects of electrocheemical detecction[76]. A
As mentioned earlier, im
mmobilizatioon of
biological prrobes such as antibodiees and DNA
A onto the sensor surfface (conduucting
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electrodes) requires highly specific binding chemistries, which may not be readily
available on a native sensor surface. Nanomaterial’s can be used to provide the required
functional sites for binding the probes to the sensor surface. The use of nanomaterials
also significantly increases the surface-to-volume function at the sensor surface thereby
leading to a high efficiency of antibody immobilization. For applications requiring high
sensitivity and low detection limits, signal amplification is a key requirement and
nanomaterials play an important role in amplifying the electrochemical response through
improved electron transport at the sensor interface. Depending on the application and
sensing technique, the dielectric properties and electrical conduction of the
nanomaterial’s can be tuned to amplify the response of the electrochemical signal[77].
Nanomaterials commonly used for electrochemical immunosensors can be broadly
categorized into Inorganic (Metal oxides, Metal nanoparticles, Graphene, CNT’s etc),
Organic (Conducting polymers, SAM’s, Chitosan, etc.), and Composites (InorganicInorganic, Organic-Organic and Inorganic-Organic).
Inorganic Nanomaterials
Nanostructured metal oxides such as tungsten trioxide (WO3), zinc oxide (ZnO), tin oxide
(SnO2), titanium oxide (TiO2), iron oxide (Fe2O3/Fe3O4), silica (SiO2) etc have been used
as sensing materials[78-80]. At nanoscale, metal oxides possess properties that are
significantly different from their coarse-grained polycrystalline counterparts, which leads
to improved sensing characteristics[81]. A high degree of crystalline and atomically sharp
terminations have made them very promising for a better understanding of sensing
principles and for the development of a new generation of sensors. In these sensors, the
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surface effects dominate the bulk properties, because of enhanced properties such as
catalytic activity and surface adsorption [79-82]. The utilization of these nano-platforms
has reduced sensing instabilities caused by drift in electrical properties[83]. Metal oxide
nano-crystals can be used as resistors, in field effect transistors (FET) and optical based
sensors [79-82, 84]. These nanostructures have revealed good sensing properties and low
power consumption in experiments, allowing for large scale manufacturing of wellorganized nanostructured sensor arrays [85, 86]. However, better growth control is still
required for widespread commercial applications [81, 82].
Organic Nanomaterials
Organic semiconductor nanostructures offer the possibility of creating tailor-made
materials, for detection of a wide range of biomolecules. Organic semiconducting
polymers have also been found to be suitable for microelectronic device fabrication, due
to their excellent electrical characteristics [87-93]. These conducting polymers and other
conjugated polymers have been used as the active layers in gas sensors since early 1980s
[87]. The optical, electrical, and molecular properties of these continue to be improved,
through synthesis of their composites and blends ensuring improved sensing applications
[94-96]. Nanostructured conducting polymers such as polyaniline (PANI)[97, 98],
polypyrrole (PPy)[99], polythiophene[100] etc. exhibit sensing behavior because of their
desired functionality, conductivity and order. A detailed discussion on PANI is presented
in chapter IV. Majority of the reports on these polymers is focused on tailoring optical
and electrical properties at nanoscale [101]. Recent studies have highlighted the
functional properties of conducting polymers for device fabrication. Many of the devices
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based on these nanostructured materials have shown poor sensitivity and slow response
time because the functional properties were not fully understood [102]. Improved
understanding of functional properties provides opportunities to synthesize new
nanostructured conducting polymers that addresses the above [101, 103]. Another class
of organic nanomaterials referred to as self-assembled monolayers (SAM) are discussed
in detail in Chapter V.
Organic-Inorganic Hybrid Nanocomposites
Organic-inorganic hybrid nanocomposites are a fast growing area of research in
advanced functional materials science. Significant efforts have been focused on the
ability to obtain nanostructures of desired shape, size, and properties using innovative
synthetic

approaches

for

various

applications[84].

The

properties

of

hybrid

nanocomposite materials depend not only on the properties of their individual
constituents, but also on their morphology and interfacial characteristics [104-108]. The
surface modification and functionalization of nanoparticles, covalent attachment, selfassembly, and ease of organization on the surfaces provides a means to generate
nanocomposite materials with tunable surface properties [84, 104]. There is also a
possibility of the realization of new properties that are unknown in the constituent
materials. Efforts are continuing towards the preparation of new nanocomposite materials
to obtain novel properties [84, 105, 109, 110]. There is a strong interest in using nano
metal/metal oxides as additives in the functionalization of polymers (conducting/bio
polymer), and significant research activities have been undertaken in nanocomposite
science for device applications[111, 112]. In nanocomposites, inorganic nanoparticles can
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be metal oxides, three-dimensional, two-dimensional, one-dimensional, and zerodimensional nanomaterial’s. Experimental studies have shown that incorporation of
mentioned inorganic nanomaterial’s into the polymer matrices leads to organic-inorganic
nanocomposites of enhanced and improved properties. Moreover, some new properties
are also observed, that are absent in the counterpart molecules [113-115]. Additionally,
they provide desired model systems for sensor fabrication. Therefore, nanocomposites
have been used for a wide range of applications e.g., high energy radiation shielding
materials, microwave absorbers, optical limiters, polarizers, sensors and hydrogen storage
systems[114, 116-120] [84, 115, 116, 120].
Other than interfacial interaction, control of nanoparticle morphology is an
important aspect that influences the nanocomposite performance. Hence in a
nanocomposite development effort, a long-term goal of development of new synthesis
strategies to control the size, shape and composition are very important. This control
allows for the tuning of nanocomposite properties[112]. Depending upon the nature of
the metal or metal oxide and polymer structure, these processes lead to the incorporation
of inorganic nano-moieties into the polymer backbone via different electrostatic
interactions[112]. Hybrid nanocomposite thin films containing metal or semiconductor
nano-crystals and polymers exhibit porous structure[117]. This enables the biomolecules
to readily adsorb onto the nano-crystals of the nanocomposite film and show a strong
sensing behavior [104, 109, 112, 116]. Recently, it has been demonstrated that it is
possible to develop suitable techniques for these materials, which are often sufficient to
yield high quality nanocomposite films [112, 118, 120].
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In this research, focus has been on organic and organic-inorganic composite
nanomaterials. Self-assembled monolayers (SAM) due to many attractive features such as
desired functional group for immobilization of anti-bodies and binding to gold substrate,
repeatable and stable fabrication process, good control over fabrication process and
uniform morphology is chosen as the nanomaterial for functionalization of electrodes
with anti-cortisol antibodies. Alternatively, an organic-inorganic nanocomposite of
Polyanaline, a conducting polymer and Ag/AgO, metal/metal-oxide nanoparticles has
been explored for demonstrating improved sensing range in a mediator free sensing
scheme. The use of the hybrid nanocomposite is expected to increase the signal response
due to the conducting nature of the nanomaterial and also improve the loading capacity of
the anti-cortisol antibodies. The presence of redox sites on Polyanaline (PANI) results in
the self-reduction and oxidation of PANI reducing the need for a redox probe (mediator)
in the electrolyte. These topics are discussed in greater detail in further chapters.
2.2 Microfluidics
Microfluidics is an application of MEMS, dealing with the study and development
of micro and nano-liter fluid volume based analytical devices[121]. Microfluidic systems
offer many advantages over conventional bench top analytical systems such as small
sample volumes, low energy consumption, utilization of micro and nano scale
phenomenon, miniaturized form factors, portability, faster response time and
disposability. These advantages of microfluidic devices make them the fundamental
building block of point of care technologies. Microfluidics is a highly interdisciplinary
field that brings together electronics[122], physics[123], biotechnology[124], optics[125],
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material science and chemistry[126].Typical microfluidic applications are focused on
continuous flow devices for detection and counting of biological entities[127],
biosensing[128] of protein biomarkers, microarray biochips for electrophoresis and
polymerase chain reaction (PCR) amplification [129], optofluidic systems for tunable
microlens arrays[130] and microfluidic fuel cells[131].
The biggest application that drives the development of microfluidics technology is
point of care diagnosis[132, 133]. In this day and age, where early diagnosis can
significantly bolster efforts to fight ailments ranging from lifestyle diseases (e.g. diabetes,
stress), conditions arising from cancer, infectious diseases and bio-terrorism threats, the
need for continuous monitoring of target analytes at point-of-care is imperative. Ideal
point of care systems need to be portable, of low form factor, be disposable,
biocompatible, produce instantaneous results from raw samples and yet maintain a low
cost per unit[134]. Microfluidics offers the potential to satisfy all these demands. The
point of care system finds applications mainly in the biomedical and environmental
sensing domain. For biomedical applications, point of care systems are best suited for
personalized health diagnostics for day to day monitoring of physiological variables,
prognostic kits for cancer, and applications in third world countries, where complete
medical diagnosis is unavailable.
Food safety and environmental pollution monitoring are becoming new priority
areas for human health care in today’s day and age. Materials such as carcinogenic
organic solvents, toxic materials, and even nuclear contamination (e.g. recent earthquake
in Japan leading to nuclear contamination in water bodies) which are very hazardous for
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environment and human health are found in packaged foods, water bodies and air. Also, a
wide range of environmental problems such as global warming, ozone layer depletion,
acid rain, increase in harmful waste materials in the environment, dioxin, and pollution of
air and water require solutions. Therefore, environmental monitoring is crucial to protect
public from toxic contaminants and pathogens that can be released into air, soil, and
water. Point of care detection systems, which provide real-time quantification of
environmental and health hazards, is the need of the hour[135].
2.2.1 Microfluidic Flow
Liquid flowing through a fully covered channel can be characterized using the Reynolds
Number (Re), given by:

=

µ

Where, L is the critical length scale (typically the diameter of the channel), Vavg is
the average velocity of the flow, ρ is the fluid density and u is the viscosity of the liquid.
Re is a non-dimensional number that is used to determine the flow regime of the liquid. A
Re number below 2000 is considered laminar and above 2000 is considered turbulent in
nature. Since the Re is directly dependent on the diameter of the microchannel, Re
numbers are typically very small in microchannels, indicating laminar flow. In the
laminar flow regime, the motion of liquid follows a predictable velocity pattern as
opposed to turbulent flow indicating a highly random and chaotic flow pattern. Also,

39

since surface to volume ratio increases by several fold at the microscale, surface forces
such as surface tension, capillarity and Van der Waals forces dominate.
The Navier-Stokes equations, which are derived from the principles of conservation of
mass (continuity), momentum (conservation) and energy (1st law of thermodynamics),
can be used to describe and predict flow of Newtonian fluids such as water and many biofluids through a control volume. With knowledge of the applied pressure differential (ΔP)
and the average flow rate (Q), the Navier-Stokes equations can be solved for rectangular
microchannel geometry in terms of fluidic resistance (Rf), and is given by:

t

+

∗ ∇v = −∇p + ∇ ∗

+

Fluidic resistance is an important parameter that can be numerically derived, as an
indicator for resistance to flow of fluid in the microchannel. As can be seen from
equation, the fluidic resistance is dependent on the geometry of the channel and plays an
important role in the design of microfluidic channel geometries.
2.2.2 Types of Microfluidic Flow
Capillary Flow
At the microscale dimensions of the microchannel cross sections, capillary forces
and surface tension forces play a significant role and can be utilized. The small cross
section of a typical microchannel and the high surface-to-volume ratio creates a large
enough capillary force to drive fluids in microchannels that are of typical lengths in

40

microfluidic systems. An important contributing factor along with the geometry of the
channel cross section is the surface energy of the channel walls that determines the
hydrophobicity/hydrophilicity of the surface. A hydrophilic surface contributes
significantly to the capillary force. Capillary drive flow can be a very inexpensive
alternative to transport fluids, without the need for external bulky devices such as pumps.
However, this method is severely limited by the microchannel design and does not allow
for real-time control of flow rate and directionality.
Pressure Driven Flow
Pressure driven flow is generated by applying a positive pressure (infusion) or a negative
pressure (withdrawal) to drive fluids in a microchannel. The flow profile of fluid in a
microchannel induced by pressure driven flow behaves as Hagen-Poiseuille flow,
displaying a parabolic shape function with maximum velocity at the center of the channel
and zero velocity at the channel walls (Fig. 10a). This condition is referred to as no-slip
boundary condition. Pumps that are used to create pressure driven flow are typically
based on a stepper motor that is connected to a linear displacement transducer. The
rotation steps in the stepper motor can be precisely calibrated as a function of flow rate.
Electro-osmotic Flow
Electro-osmotic flow relies on the movement of ions in a fluid closer to the channel
surface. This is achieved by ensuring that the inner surface of the microchannel is
appropriately charged either naturally or through surface modifications to add charge.
Then, an electric field is applied along the length of the microchannel resulting in ions in
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th
he liquid mo
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Fig 2.10 Scheematic illusttration of flo
ow profiles seen in (a) P
Pressure driiven flow annd (b)
Electro-osmo
E
otic flow.

Electrowettin
E
ng Driven Fllow
A more recen
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an
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o droplets and
a precise control
c
on thhe directionaal movemennt of the droplets.
This
T
techniq
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teechnology iss called Elecctrowetitng-o
on-dielectriccs (EWOD). Fig. 11 pressents a schem
matic
of the arrangement of eleectrowetting
g driven dropplet movem
ment. The sett-up consistss of a
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Fig 2.11 Scheematic illustrration of electrowetting of droplet foor achievingg droplet trannsport
on
n individually addressab
ble electrodees.

2.2.3 Fabrica
ation of Miccrofluidic Devices
Silicon and Glasss have long been
b
the maaterials of chhoice for miicrofluidic ddevice
development.. Silicon miccrofabricatio
on using ME
EMS based pprocessing teechniques iss very
well
w characteerized for prrototyping microfluidic
m
devices. M
MEMS proceessing involvves a
prrocess of seequentially depositing,
d
patterning
p
annd etching pprocesses a silicon subsstrate.
Fig. 12 preseents a schem
matic describ
bing the bassic processees involved in MEMS bbased
faabrication on
n silicon, glaass and polym
mer substrattes.

43

Fig 2.12 Scchematic illu
ustration of th
he three basiic processingg steps in microfabricatiion.
Silicon however has inheren
nt drawbackks such as eexpensive ccleanroom uusage,
op
pacity and impermeability to gasses. Developpment in ppolymer scieence has leed to
im
mprovementt in processsing of poly
ymers leadinng to appliications in several aveenues.
Whitesides
W
et.
e Al [136]] demonstraated the usee of polydim
methylsiloxaane (PDMS
S), an
orrganosilane,, for the fabrication
f
of
o microfluuidic structuures using soft lithogrraphy
teechnique. So
oft lithography involves a series of techniques that are based on repliccating
sttructures on the basis off master-molld patterningg and stampping of therm
mally curablee and
ph
hoto-curablee polymers. Fig. 13 pressents the schhematic expplaining the simple technnique
of making miicro-patternss in a curablee polymer ussing a microfabricated m
master.
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Fig 2.13 Scheematic illustrration of thee processing steps in fabrrication of P
PDMS structuures
using soft lith
hography.
Signifficant effortss went into th
he adaptatioon of polymeer processingg techniquess such
ass injection molding,
m
nan
no-imprint litthography annd hot emboossing for miicrofluidic ddevice
prrocessing. Polymers
P
su
uch as PDM
MS, PMMA, SU-8, Tefllon etc., havve characterristics
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uch as tran
nsparency, ease of su
urface modiifications, llow electriccal and theermal
co
onductivity, biocompatiibility, and flexible subbstrates, thaat has madee them attraactive
materials
m
for demonstratiion of lab-on
n-chip appliications[137]. Today, thhere is signifficant
liiterature avaailable on polymer
p
matterials basedd microfluiddics; howevver, there reemain
many
m
challen
nges in progrress of the polymer
p
baseed microfluiidic chips innto the next stage
of technology evolution, which is commerciallization. Siliicon and poolymer materials
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essentially use a lithography based fabrication technology which involves thin film
deposition and etching techniques combined with photolithography to define patterns that
create microfluidic structures such as channels, reservoirs, vias and valves. Lithography
based approach confines the development of microfluidic structures to 2D, requiring
multiple lithography steps to create 3D structures. Alignment errors introduced during
lithography and leakage in bonding of the multilayer microfluidic devices can cause
device failure. Since the processing is sequential, failure during any one processing step
leads to total process failure. While polymer materials are relatively inexpensive
materials, only a handful of polymers are processable and cost of lithography-based
fabrication is significantly high. Another perceivable drawback from polymer based
microfluidic systems is the incompatibility for integration with on-chip support
electronics.
Material selection is a crucial part of microfluidic system development as it
impacts the processing, functionality, application and disposability of the sensor strips
and the fluidic manifold. Processing related details such as fabrication technique,
integration with support structures and hermiticity are directly affected by the material
used. Functional aspects of a microfluidic device such as capillary forces in
microchannels, hydrophobicity and nonspecific adsorption of the sample analyte are
determined by the material chosen. The choice of material also determines corrosiveness,
temperature isolation and hermiticity for applications in implantable sensors and harsh
environments.
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2.2.4 Low Temperature Co-fired Ceramics (LTCC)
To overcome the challenges in current processing technology and materials
available, newer materials are constantly being investigated to add novel functionality
and processing capability for microfluidic device fabrication. Ceramic based
microfluidics is one such approach that offers many novel structural and functional
capabilities in microfluidic device design and fabrication. In recent time, low temperature
co-fired ceramics (LTCC), a material used extensively in the IC industry as a packaging
material over the last two decades, has gained attention as an alternative to glass, polymer
and silicon for the fabrication of microfluidic systems[138-142]. LTCC offers a number
of advantages over polymers, glass and silicon, making it an ideal material for developing
microfluidic devices[143]. Since the beginning of 1980’s, LTCC has been extensively
developed as a microelectronic packing material in multichip modules. A representative
LTCC device consists of a multilayer stack of sintered ceramic tapes, each of which
contains passive electronic elements such as resistors, capacitors and inductors buried in
it. The various layers are interconnected through via filled with conducting materials such
as gold (Au) and silver (Ag) paste.
LTCC, due to its inherent properties such as chemical inertness, biocompatibility,
high-temperature stability, low thermal conductivity, excellent dielectric properties,
mechanical strength, packaging capabilities and three dimensional structuring lends itself
well for the development of microfluidic devices[139, 144]. LTCC as a material for
development of microfluidic based systems has shown promise in overcoming the
important drawbacks of polymer microfluidic systems. LTCC based fabrication aids
rapid prototyping with a significantly low turn-around time in a semi-clean room
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environment with minimal use of expensive tools compared to conventional clean room
based microfabrication techniques[145]. The parallel processing of the multiple layers
and final integration into a multilayer stack easily accommodates design modification
during initial device development. The maturation of the microelectronics packaging
technology using LTCC allows for integration of the fluidic system with the support
electronics needed for microfluidic operation and automation[138]. The sintering
temperature of LTCC (850ºC) allows for integration of sensing and actuating electrodes
using precious metals such as Au, Ag, Pd and Cu. This is a significant advantage over
high temperature co-fired ceramics (HTCC) which allows only the use of refractory
metals such as W and Mo[146]. At reasonable feature sizes, the integration of the
working metals such as Au, Ag and Cu can be performed using a standard screen printing
process. The relatively simple and inexpensive fabrication methods also lend itself to
economical manufacturing in large scale. The multilayer approach accommodates the
incorporation of three dimensional structures and high aspect ratio features such as
overlapping microchannels, which is otherwise a tedious and complicated process in
lithography based microfabrication requiring repeating steps of sequential lithography.
Leakage, one of the common challenges faced in microchannel bonding to substrates is a
non-issue in LTCC microfluidics since all the layers are co-fired, resulting in a leak free,
compact microfluidic manifold. LTCC, post fired, is also a mechanically stable, swell
free, corrosion resistant material.
In terms of the material properties, LTCC demonstrates an equal or better
performance compared to silicon, polymers and glass. Table.1 provides a comparative
summary of the relevant properties of LTCC, Silicon, Polymer and Glass.
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LTCC
DuPont 951

Silicon
<100>

PDMS

Glass
(Borosilicate)

320
120
3.1
13, 13, 15

700
140
2.329
-

2.24
0.0018
0.97
-

69
64
2.23
-

Expansion Coefficient (10-6 / C)

5.8

2.7

310

3.2

Conductivity (W/mK) @ (25-300C)

3

120

0.15

1.1

7.8 (10MHz)

2.32

2.3-2.8

4.6 (1MHz)

Mechanical
Flexural Strength (MPa)
Young’s Modulus (GPa)
Density (g/cm3)
Shrinkage (X, Y, Z) %
Thermal

Electrical
Dielectric Constant
Resistivity (Ωcm)

12

> 10 (100V DC)

> 10

5

> 10

14

> 1015

Table 2.1 Comparative table of the properties of LTCC with silicon, PDMS and Glass.
Low temperature co-fired ceramic (LTCC) and high temperature co-fired ceramic
(HTCC) are the two raw ceramic substrates used in the manufacture of multilayer
ceramic substrates. The primary difference between the two comes from the material
composition and firing temperature of the two materials. The main constituent of HTCC
ceramics is Al2O3, which requires a high sintering temperature around 1500C. The high
sintering temperature used for HTCC processing poses limitations, which include
incapability to integrate passive electronic components such as resistors and capacitors
and use of refractory metals only. LTCC, adapted from the HTCC technology, is an
amalgamation of Al2O3 (45%) and glass (40%) buried in an organic binder (15%) [146].
The constituent materials and their proportions are chosen to thermally match the
sintering temperature of 850C, which is significantly lower than the HTCC sintering
temperature. The lowered sintering temperature allows for the integration of resistors and
capacitors and also the co-firing of screen-printed metal on the ceramic substrates. A
sintering model for the ceramic-glass composite system has been proposed by GongoraRubio et. al.[139]. The unfired ceramic tapes consist of Al2O3 and glass granules
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dispersed in an organic binder. At sintering temperature, the glass granules melt and
surface tension and capillary forces facilitates the encapsulation of the sintered Al2O3
granules. Annealing results in the formation of a dense ceramic structure.
2.2.4.1 LTCC Processing
The unfired ceramic material is available in the form of sheets and is referred to
as green tape, the color green representing the unfired state of the ceramic. Fig. 14a
presents a schematic of a standard LTCC fabrication process. The process starts by
defening the substrate size and number of layers. In LTCC fabrication, all the layers that
constitute the final device are processed parallely. After the substrate size is determined,
the design features such as channels, grooves and vias are created using patterning tools
such as laser cutting, punching heads, jet-vapor ethcing and CNC machines. Feature size
is dependant on the patterning tool used with typical feature sizes in the 10 to 100μm
range. Conducting vias used as interconnects across layers are formed by filling the
punched vias with conducting inks of Au and Ag. Electrical conduction lines and
sensing/actuation electrodes are formed by screen printing. The individual layers are then
stacked using an aligning chuck and a prefiring lamination step is performed at a pressure
of 3000psi and temperature of 150C for 8-10 minutes. The lamination step is performed
to temporarli bind all the layers while in the aligning chuck. The laminated LTCC device
is then sintered in a programmable furnace. The temperature ramping profile is a critical
parameter during sintering with slow ramping rates recommended to avoid thermal
stresses and shrinkage mismatch between layers. At lower temperatures (200 to 400C),
the organic materials burn out, and this step is critical for successful fabrication of
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microfluidic structures such as microchannels and vias and is discussed elaborately in the
next section. At the sintering temperature of 850C, the glass granules melt and
encapsulate the ceramic granules forming a homgenous structure across all the individual
layers. Fig. 14b presents a typical firing profile for Dupont 651 and Ferro A6 green tape.

Fig 2.14 (a) Schematic illustration of the processing steps in LTCC based
microfabrication; (b) Temperature ramp profile during the sintering process of LTCC
structures.
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The burning out of the organic materials, which constitutes about 15% of the total
composition of the green tape results in a proportional shrinkage in the overall
dimensions of the paternened structure in all the three dimensions. Hence, the shrinkage
factor is always deliberated into during the initial design of all the critical features.
Shrinkage free LTCC tapes are also available from commercial vendors such as Heralock
and ZST (Sea Ceramic Technologies).
2.2.4.2 Fabrication of Microfluidic Components in LTCC
Microchannels
The fabrication of microchannels is one of the core processes in the development
of microfluidic devices. Ideal design features of microchannels include vertical side
walls, zero dead volumes, leak free connection to inlet and outlet fluidic connectors, leak
free bonding to adjacent layers in multilayer architectures, low surface roughness and
uniform cross section across the length of the channel to maintain the dynamics of the
fluid flow.[147] The most compelling problem faced during microchannel fabrication
using LTCC technology is the occlusion of the microchannels due to collapsing of the
LTCC layers during lamination. To overcome this challenge, many modifications to the
standard LTCC process flow have been reported. One of the popular approaches to
overcome the channel sagging, or collapsing, has been to use a sacrificial material to fill
the empty spaces in the microchannels prior to lamination[148]. During the lamination
process the sacrificial material provides the mechanical support required to maintain the
structural integrity of the embedded microchannels and during the sintering process, the
sacrificial materials burn out leaving a void that forms the empty microchannel.
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Golonoka et. al[149] have reported the characterization of an LTCC based microchannel
fabrication process using carbon-black paste and cetyl alcohol as the sacrificial materials
with the DuPont DP 951 green tape. A similar characterization of the microchannel
fabrication process has been reported using high purity carbon paste, carbon tape and
cetyl alcohol with zero-shrinkage green tapes from Heraeus HL2000[150]. Scanning
electron microscopy (SEM) has been used to characterize the cross section of the
microchannels fabricated using the different sacrificial materials as fillers. Significant
improvements have been demonstrated leading to decreased sagging and channel
constriction. The use of sacrificial materials requires a well-characterized temperature
ramping profile during sintering to allow the complete burnout of the sacrificial material
to avoid residual retention in the microchannels after sintering. An alternate technique for
overcoming the channel collapse and sagging issue, without the use of any sacrificial
materials has been reported by Shafique et. al [151]. The technique uses the method of
progressive lamination, where in, the lamination of the layers is performed multiple times
individually at low pressures and also after aligning the layers in a progressive manner.
This method, implemented successfully, provides a few notable advantages. Since the
pre-lamination and post-lamination process is identical, the overall process flow is not
disturbed. The process is also considerably simplified by overcoming the use of
sacrificial materials. The progressive method of lamination may however lead to a poor
binding between the pre-laminated individual layers and can cause delamination of the
layers during sintering. The delamination can lead to leaky channels and can cause
bonding and peeling issues at integration and packaging stages. To overcome issue
arising from channel collapse and delamination, more recently, Deisinger et al [152] have

53

reported the usage of low temperature, low pressure lamination along with double sided
adhesive tapes as the sandwich between the ceramic layers. This modification allows for
the fabrication of cavities with very low aspect ratio (0.5mm: 15mm) with no observable
sagging. µCT (Computer Tomography) has been utilized here for the non-destructive
analysis of the internal features of the multilayer ceramic structure. Maeder et al. [153]
have reported the characterization of various compositions of hot melt adhesives as an
alternative to adhesive tapes. The potential advantage of these hot melt adhesives is that
the adhesives can be applied as thin film on the ceramic substrates in its green state and
the subsequent processing steps for LTCC microfluidic device fabrication are not
affected.
Optical Windows
A perceivable drawback of using LTCC based microfluidics is opacity of ceramic
material. Transparency is a critical factor for applications involving optical detection such
as fluorescence in µTAS systems. One of the approaches to overcome this challenge has
been the use of a hybrid LTCC-Polymer or LTCC-Glass systems, in which, the
microchannel and the underlying structure is made from LTCC and the top most layer
that covers the microchannel and consists of the i/o fluidic ports, is made from a
transparent substrate such as PDMS or Glass. A technique for the bonding of LTCC
substrates to PDMS has been reported by Malecha et. al. [154]. The laminated LTCC
structure is first coated with a glaze layer using screen printing[155]. The glaze layer
essentially forms a glass coating after the sintering process. Oxygen plasma exposure,
that creates free radicals on the surface of PDMS and Glass that assists in the formation
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of covalent bonds between the two materials, is a well characterized process to obtain
irreversible bonding for PDMS-PDMS, PDMS-Silicon and PDMS-Glass [156]. The same
approach has been used to bond the PDMS cover to the glass covered LTCC substrate.
The bonding between the glass covered LTCC substrate and PDMS provides a
mechanically durable, leakage free, irreversible bonding. Pawel et. al. [157] report the
integration of transparent glass windows into the LTCC substrate to aid in optical
applications of LTCC microfluidic devices. A thin glass wafer is used as one of the layers
in the LTCC stack. During the sintering process, temperatures in the 670 ºC to 720 ºC
range initiates the softening of glass, but the surface tension forces of the molten glass
help in maintaining the structure of the glass sheet. At the LTCC sintering temperature,
glass is conformal enough to accommodate the shrinkage of the LTCC substrate, while
being strong enough to maintain its shape. This advancement lends itself well to the
development of LTCC devices for optical sensing and actuation applications.
Simulation of fluid behavior
Fluid flow behavior in microchannels has been a key point of focus in the area of
microfluidics research [123]. Microchannel geometry, surface roughness, hydrophobicity,
surface tension and viscosity of the fluid are some of the factors that determine fluid
dynamics in microchannels. Rapid and complete mixing of buffers, analytes and reagents
is a critical requirement for chemical analysis and biosensors based microfluidic systems.
By understanding the fluid dynamics in microchannels and with careful design of the
microchannel geometry, passive mixing of fluids can be achieved. The opacity of LTCC
material can cause issues while characterizing fluid flow in microchannels. Especially in
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micromixers and microreactors, where determining the mixing efficiency and the effect
of microchannel geometry on mixing is important, flow characterization is not straight
forward. Computational fluid dynamic (CFD) simulation can be a very useful tool in
predicting fluid behavior and aid in design of efficient microchannel geometry. Malecha
et. al. [158] have reported the fabrication of microfluidic micromixer using LTCC
technology. A detailed computational fluid dynamic (CFD) modeling of fluid flow under
(a) steady-state, laminar flow and mixing of incompressible fluids and (b) an application
example of two chemicals, 1- and 2- naphthols has been reported. The findings from the
CFD modeling, such as the effect of inertial and viscous forces on mixing efficiency,
have been experimentally verified using a prototype I-shaped serpentine microchannel
fabricated using standard LTCC processing. The aid of modeling and simulation has also
been used to study the deformation and failure of LTCC layers to design and obtain
optimal microchannel dimensions. The use of computer modeling to understand fluid
flow behavior in LTCC microfluidic devices has also been presented by Schlottig et. al.
[159]. The network approach based model which describes stationary flow in LTCC
channels of non-circular cross sections, is essential due to the variance introduced in
microchannel cross section and geometry fabrication using LTCC processing.
Computational modeling has also been utilized to optimize application specific
microfluidic designs. In an effort to optimize the microfluidic design for an optic fiber
based optofluidic system, Malecha et. al. [160] have reported CFD simulations to
understand the effect of fluid inlet and outlet spacing on the transmission of light in the
microchannel. The set-up consists of three different microchannel designs (П type, L type
and I type) with varying inlet and outlet configurations. The CFD simulation of fluid flow
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in the three different configurations indicate that the L type and I type structures showed
decreased signal due to localized disturbances in fluid flow causing significant
repeatability issues. An experimental approach for characterization of fluid flow in LTCC
microchannels has been reported by Groß et al.[161]. Pressure drop method, which uses
the pressure drop along the length of the microchannel and its corresponding friction
factor to calculate flow rate as well as mixing efficiency. Another method described is the
resistance time distribution measurement, which is based on the residence time of a liquid
packet in a microchannel and its effect on mixing efficiency and yield. A pulse trace
assembly is used to inject pulses of the experimental liquid and post processing on the
recorded pulses and signal is used to understand the fluid flow behavior and mixing
efficiency.
2.2.4.3 Applications of LTCC Microfluidic Systems
Microreactors
Microfluidic microreactors are increasingly gaining importance in biosensors,
chemical synthesis and pharmaceutical research applications due to the many advantages
such as excellent control over process parameters (temperature, pH, and humidity, etc.).
Microreactors also aid in pilot small volume R&D activities, which is typical in chemical
synthesis and drug discovery applications[162]. With the need for point of care systems
gaining ground, microreactor technology has found good application in biosensing and
PCR based systems, which require highly controlled environments in a microchamber
[163]. Microreactors require the integration of multiple sensing and actuation
components such as micromixers, microextractors, microheaters, microsensors for
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temperature, pH, humidity and redox measurements and many more depending on the
demands of the application[164]. Polymerase chain reaction (PCR) is a powerful
biotechnology tool finding many applications in the fields of science and medicine. PCR
can be used to identify genetic diseases, detect infectious diseases, identify cancer types
and also in forensic sciences for high accuracy matching and identification of human
samples. PCR essentially creates multiple copies of a target DNA fragment through a
sequential thermal cycling process. Traditionally, the PCR process is carried out in a
laboratory using vials, however, advancement in microfluidics and microsystem
fabrication technology has allowed the creation of portable and compact devices that can
be used at point-of-care and can produce real time results known as real-time PCR
(rtPCR). The success of microfluidic PCR systems is highly dependent on the creation of
three temperature zones on a single chip with high stability, while being thermally
isolated from each other. Typically, metals such as nichrome and scandium are
microfabricated onto the substrate to form microheaters, and the samples are transported
between the thermal zones using microchannels. Silicon, glass and polymers have been
previously used as materials to create microfluidic channels in PCR systems. LTCC, due
to its high thermal isolation, biocompatibility and microfluidic processing capabilities can
prove to be a better candidate for PCR applications. Malodobra et al. [165] have reported
a study comparing the specificity, sensitivity and efficiency between traditional PCR
systems and LTCC based PCR systems. Bembnowicz et. al. [166]have reported the
development of a LTCC based microfluidic system for DNA amplification and
measurement using PCR. The LTCC system consists of a microchamber which forms the
integral part of the microreactor. Temperature control is provided using a thermoelectric
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module and a micro-thermistor for measurement. The detection system, optical based,
consists of a fiber optic laser light source that is integrated into the LTCC chip and a
CCD camera captures the fluorescent light emission using special filters. The developed
system has been successfully tested for DNA measurement. An improvement to the
above mentioned LTCC PCR system has been reported[167] . Here, the temperature
control which consists of the microheater and the sensor are integrated into the LTCC
substrate, thereby creating a more compact form factor for the envisioned system. A
commercially available SMD (surface mount device) resistor is used as the microheater
and a Pt100 element is used as the temperature sensor. Along with the heater and sensor,
the support electronics are soldered onto the LTCC substrate. An additional metallic layer
is screen printed to improve the thermal conductivity and achieve uniform temperature
distribution in the microchamber. In the above two reported developments, the sample is
held stationary in the microchamber, while the temperature is cycled between three
distinct temperatures using the embedded heaters. Another popular configuration for PCR
microfluidic systems is to sequentially transport the sample between three chambers, each
maintained at the required temperature. Sadler et. al. [168]have reported the development
of an LTCC platform for PCR and DNA detection using a continuous flow microfluidic
system. Microchannels connect the three temperature zones which are realized using
screen-printed Ag-Pd. Temperature sensors are surface mounted onto the LTCC
substrate. One of the salient features of this design is the introduction of air-gaps between
the parallel microchannels to provide thermal isolation during sample transport between
the temperature zones. The functionality of the LTCC based continuous flow microfluidic
system is demonstrated by performing real-time PCR and also DNA detection. Another

59

fine example of the 3D architecture capability of LTCC processing has been
demonstrated in an LTCC based microfluidic microreactor developed by Smetana et al
[169, 170]. The system consists of a spherical reactor cell for accumulation and mixing of
reagents and other solutions. The system also consists of sensor arrays for monitoring of
pH-, oxygen-, temperature and iodide sensitive sensors. A surface mount optical glass
fiber is used reaction monitoring using absorption or fluorescence spectroscopy analyses.
Temperature control is provided by pumping a thermal fluid through embedded ducts. A
network of micro-channels with cross-section dimensions varying from 200mm x 200mm
up to 2mm x 2mm is connecting the different measuring sections within the ceramic
module.
Whole Cell Sensors
Cell cultures have been a great source of information for understanding the
growth dynamics in the human body. Cell cultures are extremely sensitive to
environmental variables such as temperature, pH, humidity, ion concentrations, nutrients
and pathogens in the culture media. Monitoring, regulation and response of cell cultures
to triggers is a huge area of research that acts as enabling feature in drug discovery and
toxicology. An LTCC based microelectrode array for monitoring of cell cultures has been
reported by Ciosek et. al[171]. The microelectrode array is realized by screen printing of
Pd-Ag paste and electrochemical deposition of AgCl. The microelectrode array is
functionalized with ion selective membranes of high selectivity for monitoring and
detection of various cell culture variables such as cell culture media change, cell growth
rate and toxicity levels. Electromagnetic force (EMF) is utilized to detect the changes in
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electrode response due to the ion concentration variation. Principle component analysis
(PCA) is used to segregate the multiplexed data obtained from the sensor array. Bioparticle detection and counting has come into focus in the modern day due to the high
potential of impact on daily life due to presence of harmful chemicals and biological
elements in the environment and other consumables. Bio-terror threats and spreading of
allergens and bacteria in public places such as airports also require deployment of sensors
that monitor and detect bioparticles. Flow cytometry is one of the most successful
technologies used to detect particle concentration and size in a rapid manner. Malecha et.
al.[172] have reported the development of a LTCC based micro cell analyzer for
detection and counting of bioparticles. The LTCC based system works on fluorescenceactivated detection in a flow cytometry set-up. The ceramic microfluidic system consists
of a microfluidic chamber, microchannel, optic fibers, light emitting diode (LED) and
photo detector embedded into the LTCC substrate. The integration of all the active and
passive components of the system into a single substrate provides a form factor that is
realistic for commercial applications. E. Coli and Saccharomyces cervisiae cells are used
to demonstrate the functioning of the developed micro cell analyzer.
Biosensors
Biosensors are integrated small devices that employ a biological element such as
an antibody, enzyme, receptor protein, nucleic acid, and cell or tissue section as the
sensing element. Typically, a nanostructured matrix such as self-assembled monolayer,
carbon nanotube, metal oxide or other nanocomposite material is used to immobilize the
sensing element onto the detection surface. Various transduction techniques such as
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electrochemical, optical, acoustic, piezoelectric and gravimetry can be employed to
quantify the concentration of the analyte that is sensed. Biosensors are a promising
technology due to inherent advantages such as high selectivity, linearity, simple set-up,
electrical output, high sensitivity and easy system integration. The sensing of various
biomarkers using biosensors has been extensively researched. In recent years though, the
focus has shifted towards integrating the developed sensors into a complete system that
supports the sequencing of the sensing assays with the supporting electronics for data
acquisition and analysis. LTCC technology, which facilitates the integration of
microfluidic structures and electronic components such as resistors onto a single
substrate, and the addition of integrated circuits by surface mounting provide the most
suitable platform for developing miniaturized biosensing systems for a plethora of
sensing applications. Immunosensors, which use antibodies as the bioreceptor, are highly
preferred due to the high degree of selectivity and sensitivity that is associated with
antibody-antigen interactions. Antibody immobilization strategies are very well
characterized and are highly suitable for various transduction mechanisms such as
electrochemical and optical due to superior electron transfer and secondary fluorescence
antibody tagging properties respectively. For the fabrication of immunobiosensors, the
availability of a surface that is conducive to antibody binding is a pre requisite. Typically,
the antibody is immobilized at target areas such sensor electrode surface, while
attempting to keep the peripheral areas free of any non-specific binding. Nanomaterial
based immobilization matrices are used to improve surface to volume ratios, enhance the
sensing response and also where the direct binding between the antibodies and the sensor
surface is not feasible. With LTCC being investigated as a potential substrate material for
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the development of biosensing platforms, determination of optimum surface conditions is
imperative. In this regards, Fakunle et al. [173] have evaluated the feasibility of using
LTCC as a substrate for immobilization of antibodies on screen printed gold for
electrochemical detection. Parameters such as pretreatment conditions (piranha cleaning
v/s water), electrochemical response of the screen printed gold electrodes and deposition
of a nanomaterial immobilization of matrix such as self-assembled monolayer (SAM) on
the electrodes were characterized and optimized. Electrochemical detection of Mouse
IgG antigen using a sandwich type immunoassay was used as a model to demonstrate the
feasibility of using LTCC as a suitable substrate material for the development of
immunosensors.
Fakunle et al. [174] have recently reported the development of a complete
microfluidic system that adopts the screen printed gold electrodes (previously discussed)
into a multilayer LTCC microfluidic manifold containing microchannels. The sensing
electrodes are incorporated onto all the four walls of microchanne. Enzymatic biosensors
are also a popular choice of bio-receptors due to their rapid, efficient and selective
detection of important analytes such as glucose, cholesterol, urea and lactic acid.
Enzymatic biosensors have found success in commercialization and have proven their
potential for point of care diagnostics and personalize health care. Malecha et al.[175]
have reported the use of an enzyme based LTCC microfluidic biosensing platform for the
detection of urea in biological fluids. The system design consists of a micro reactor
chamber, an integrated micro heater and temperature sensor. Micro glass beads are used
as the enzymatic carrier to determine the concentration of urea by measuring the pH at
elevated temperatures. The enzymatic reactions are enhanced at elevated temperatures
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(37C) using the screen printed Pt micro-heater electrodes. The temperature sensors are
realized by screen printing of a resistance-temperature dependent ink (DP 3630). The
developed sensor is successfully tested for urea concentration determination in biological
fluids. The system also demonstrates impressive shelf-life and repeatability (18 days).
Another example of a LTCC based enzymatic biosensor has been reported for the
continuous monitoring of glucose[176]. The detection system is based on the oxidation of
glucose in the presence of the enzyme glucose oxidase, Gox. Hydrogen peroxide, a
byproduct of the oxidation reaction is used to quantify the concentration of glucose. The
sensing system, based on electrochemical (amperometric) measurements, consists of
thick film working, counter and reference electrode, a mircoreaction chamber and a semi
permeable dialysis tube running along the length of the device. The system operates by
the size selective diffusion of the glucose molecule through the semi permeable walls of
the dialysis tube into the micro reaction chamber. Glucose concentration up to 9mM was
successfully quantified at a high sensitivity of 147 nA/mM.
Environmental Monitoring Sensors
Owing to rapid globalization, a wide range of man-made chemicals and byproducts formed in industrial or combustion processes have been, and still are, released in
the environment. The toxic matter is known to adversely impact the ecosystem as well as
human life. The increasing number of potentially harmful pollutants in the environment
has resulted in stringent legislation towards environmental regulation. In order to
implement these tight regulations, analytical instruments that can provide high sensitivity,
accurate and instantaneous results in a form factor that can be deployed in remote
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locations are critical. There is a critical need to monitor contaminants and toxins in air
(volatile compounds and gases), water (heavy metals, virus and bacteria), soil (chemicals,
minerals) and food (bacteria, viruses, toxins, mycotoxins, pyrethroids, etc.). Where online
and continuous monitoring of environmental variable is imperative, traditional laboratory
based analytical methods will not suffice. Point of care systems driven by microfluidic
technology is a key player in the realization of such environmental sensors. Unlike
biomedical applications where sterility and biocompatibility are critical issues considered
during development, design criteria is mostly based on robustness and performance in
harsh environments. Packaging of the sensors to withstand harsh environmental
conditions is crucial, which is where, the use of LTCC based microfluidic systems can
provide significant advantages over most conventional microfluidic systems, such as
mature packaging techniques, inertness to harsh chemicals and gases and noncorrosiveness.
Achmann et al. [177] have reported the development of an LTCC based
microfluidic gas sensing system for the detection of formaldehyde. A biosensors
approach, where formaldehyde dehydrogenase, an enzyme, is used as the sensing element
in an amperometric sensing set-up. In order to support system integration, a ceramic
diffusion membrane has been incorporated into the LTCC stack. The typical
hydrophobicity required in the diffusion membrane is achieved by coating the ceramic
membrane with an organochlorosilane in toluene. The sensing electrodes are realized by
standard screen printing of Ag/AgCl. The sensor exhibits a low detection limit of 76 ppb
with linear response in the range 500 ppb to 10 ppm. The sensor performance is
comparable to a macro sized counterpart while requiring half the enzymes and one tenth

65

the sample size. In an effort to develop a deployable on-site microanalyzer, Garcia et al.
have [178] developed an LTCC microfluidic system for the simultaneous detection of
nitrate and chloride ions in water samples. Two set of screen printed Ag/AgCl electrodes
are used for potentiometric detection, and ion selective polymer membranes are used for
selective detection of chlorine and nitrate ions. The integrated sensor performance
demonstrated a linear working range of 10-3M to 10-1M for nitrate ions and 10-4M to 101

M for chloride ion. Similarly, amperometric determination of free chlorine using carbon

nanotube composite electrodes has been reported[179]. The use of nanocomposites
increases the system functionality and also enhances the surface renewability inherent in
composite electrodes. A noticeably lower detection limit of 0.05 mg/L of chlorine ion
was detected. Real samples collected from swimming pools were successfully tested for
determination of chlorine using the developed LTCC based sensing system.
Contamination of water bodies with metallic particulates originating as byproducts from
industrial processes is a cause for serious concern. The presence of metallic contaminants
in potable water has been correlated to many cases of carcinogenesis. An LTCC based
spectrophotometric microanalysis system [180] has been developed for the determination
of chromium (VI) in water. The microfluidic system consists of inlet and outlet
microchannels that transport the sample solution into and out of the measurement
chamber. A glass window incorporated into the opaque LTCC structure allows the use of
optical detection system such as colorimetry for determining the concentration of the
target analyte. The developed system provides a linear sensing range of 0.1 to 20 mg/L at
a detection limit of 50 µg/L. An LTCC based microfluidic system for detecting traces of
heavy metals in biological and environmental fluids has been reported by Rubio et al
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[181]. The design features of the LTCC microfluidic manifold include a spiral coil
microchannel for passive mixing of two liquids required in most electro-chemical sensing
assays and a screen printed microelectrode array that is required for the electrochemical
detection technique. An important part of the chip fabrication is the precise alignment of
the electrode array with the microchannels. In this work, an innovative approach has been
utilized; where in, a standard dental x-ray image is used to verify the alignment, since
visual alignment is not possible in the opaque structure. The integrated system
demonstrates detection of mercury and copper in low detection limits of 0.9µg/L and
0.45µg/L respectively in urinary fluids. The same system can be employed for detection
in environmental fluids such as river water and water bodies around industrial sites. For
the detection of organic compounds such as sulfamethoxazole (SMX) and trimethoprim
(TMP), Almeida et al. [182] have developed an LTCC- potentiometric microfluidic
device. SMX, which has been used for many years as a human/veterinary antibiotic is
now a potential threat as it is found in alarming quantities in water coming from
municipal wastewaters and aqua farming water bodies. The developed sensing system
uses synthesized antibodies as the sensing material. Molecular imprinting technique has
been used to create ionophores of SMX on a plasticized PVC membrane. The membrane
is then integrated into the LTCC microfluidic manifold for detection of SMX and
similarly TMP. The sensor displays slopes of −58.7 mV/decade for a detection range
from 12.7µg/mL to 250µg/mL at a detection limit of 3.85µg/mL at a high throughput of
36 samples/h. The sensor utilizes a sample volume of 3.3mL per sample.
Various examples of systems application of LTCC based microfluidic devices
have been reviewed. However, there remain many opportunities for further development
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of the processing techniques of LTCC to realize novel functionality and applications.
Realization of feature sizes in the nanoscale range in LTCC systems is currently limited
by the fabrication techniques. Novel fabrication techniques along with the use of new
material compositions can enable the creation of nanoscale features such as
nanochannels, nanowires and other nanotextures surfaces. Methods to integrate LTCC
with silicon, glass, and polymers can lead to the creation of hybrid microfluidic devices
that bring together the best from all the materials. LTCC microfluidic systems with
actuators for microvalves and micro pumps will be essential for realization of a standalone point of care system.
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CHAPTER III
Electrophoretically Deposited Polyanaline-Ag/AgO Hybrid Nanocomposite Based
Electrochemical Immunosensor for Mediator Free Detection of Cortisol

This chapter presents the development of a nanocomposite based immunosensing
platform for the label-free and mediator-free electrochemical detection of cortisol. Coreshell Ag/AgO nanoparticles and Polyanaline (PANI) is used to synthesize a hybrid
nanocomposite film through electrophoretic deposition (EPD) onto Au substrate. For the
first time, electrophoretically deposited Ag@AgO-PANI hybrid nanocomposite is
utilized for the immobilization of monoclonal Anti-Cab to realize a label-free and
mediator-free electrochemical immunosensing platform for cortisol detection.

3.1 Ag@AgO-PANI Hybrid Nanocomposite
Multiple charged sites, large surface-to-volume ratio, high surface reaction activity,
high catalytic efficiency and strong adsorption ability of organic-inorganic hybrid
nanocomposites has prompted their use of as an immobilizing matrix to fabricate
biosensors to enhance the signal in electrochemical biosensors [1]. Synergetic effect
between parent molecules causes high electro-activity, stability and functionality. These
properties make organic-inorganic hybrid nanocomposite as materials of choice for
various applications such as solar cells, optoelectronic, energy storage, sensors,
pharmaceuticals, drug delivery, biomedical devices etc [2].
Nanostructured PANI and its nanocomposite with metal (Au[1], carbon nanotubes[3],
graphene[4] etc.,) have already shown potential as advanced functional materials for
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sensing technology [1]. The sensing performance of PANI has been improved via
incorporating metal /metal oxide nanoparticles in its backbone. Au nanoparticle has been
incorporated in PANI backbone to improve redox-stability, electro-activity, charge
transfer kinetics, functionality, and stability of PANI. Dey et al described Au NP- PANI
nanowires composite for immunosensor fabrication to detect prostate-specific-antigen, a
biomarker used for the screening of prostate cancer[1]. Ag based nanomaterials has also
shown its potential in sensing technology especially enhancing performance of biosensors
due to its improved electro-activity and high electron transfer kinetics [5-7]. The high
isoelectric point (IEP) of AgO ~ 10.4[8] has lead to high electrostatic interactions with
biomolecules (IEP ~ 4.2) due to the large differences in surface charges. PANI-Ag
nanocomposites have also been explored, however till date researchers have only focused
on its synthesis and characterization to explain improved optical and electrical properties
[9, 10], pseudo-capacitive properties [11, 12] and electrochemical oxidation [13]. The
nanocomposites of PANI-Ag have been used to detect vapours, wherein Ag enhances the
charge transfer between polymers and nanoparticles[14]. However, potential application
of these nanocomposites in biosensor development is not well explored. Hence there is
scope to investigate the use of PANI-Ag nanocomposites as the immobilizing matrix in
immunosensors.
3.2 Materials and Methods
Aniline,

1-ethyl-3-(3-dimethylaminopropyl)carbodiimide)

(EDC),

N-

Hydroxysuccinimide (NHS) and cortisol were purchased from Sigma Aldrich. The
monoclonal cortisol antibody (Anti-Cab) 2330-4809 was procured from Abd serotec. All
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other chemicals were of analytical grade and were used without further purification. The
working solutions of cortisol were prepared by dilution in PBS (10 mM, pH 7.0, 0.9%
NaCl).
The emeraldine base form of PANI was synthesized using oxidative
polymerization of aniline in acidic media using ammonium persulphate (APS) as the
oxidant [18]. Ag@AgO NP utilized in this research was obtained from QuantumSphere
Inc. The nanoparticles were prepared through vapor phase condensation process by
vaporizing Ag beyond its boiling point, until a sufficient rate of vaporization via
resistance heat mechanism was achieved.
Thin films of Ag@AgO-PANI nanocomposite were electrophoretically deposited
onto Au substrate employing colloidal suspension of PANI and Ag@AgO NP in
acetonitrile. Deposition was carried out in a two-electrode cell configuration (Fig 3.1),
with gold foil (10 mm × 30 mm) as the counter electrode (Anode) and the pre-cleaned Au
substrate as the working electrode (Cathode). 100µl of Ag@AgO NP (0.1mg mL-1 in
water) and 200µL of PANI (0.02µg mL-1 in formic acid) were added to 2ml of
acetonitrile, and sonicated for 1 minute to prepare the colloidal deposition solution. The
film deposition parameter such as time and voltage were optimized and 60V for 60s was
found suitable to fabricate electrochemically stable film with highest magnitude of
response current. EPD deposited films were washed with deionized water to remove
unbound particles and dried at room temperature in air. A standard process, reported
previously [19-21], has been utilized to immobilize Anti-Cab covalently onto Ag@AgOPANI /Au electrode. Anti-Cab was covalently bound on nanocomposite via EDC/NHS
chemistry between amine group of PANI and COOH group of Anti-Cab. The Ag@AgO-
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electrochemical response studies as a function of cortisol concentration have been carried
out using cyclic voltammetry (CV) from -0.4V to 0.4V in Phosphate Buffer Saline (PBS)
at pH 7.0 containing 0.9% NaCl. Electrochemical studies were carried out in a 5 ml threeelectrode cell with Ag/AgCl as reference electrode and Au as counter electrode using the
Autolab

Potentiostat/Galvanostat

(Eco

Chemie,

Netherlands).

Electrochemical

Impedance Spectroscopy (EIS) studies were carried out in PBS solution (10 mM, pH 7.0,
0.9% NaCl) containing a mixture of 5 mM Fe (CN)6 3-/4- as redox probe at equilibrium
potential without external biasing in the frequency range of 0.1–105 Hz with 10 mV
amplitude.
3.3 Results and Discussion
3.3.1 Optical Characterization of Ag@AgO NP & Ag@AgO-PANI Nanocomposite.
The TEM image (Fig. 3.2A) presents the uniformly distributed Ag@AgO nanoparticles
on the TEM grid. The estimated average particle size was ~ 5 nm. Due to the high surface
charge and small particle size, the nanoparticles appear to be slightly agglomerated. The
enlarged TEM image core-shell nanostructure is shown in Fig 3.2B. The high resolution
TEM study reveals that core of Ag (~3 nm) was encapsulated in a shell of AgO (~2 nm).
The observed diffraction fringes indicate the crystalline structure of core-shell Ag@AgO
nanoparticles. TEM based energy dispersive X-ray spectrum (EDX) of the nanoparticle
(Fig 3.2C) indicates that the primary constituents, Ag and O that form the core-shell
structure of the Ag@AgO nanoparticle.
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and Bovine Serum Albumin (BSA) have also been studied using AFM (Fig 3.3c). The
granular nano-porous morphology of the nanocomposite film reformed to another wellarranged nano-porous morphology with an average height of 46 nm and mean roughness
of 6.2 nm confirm the immobilization.

A

B

C

Fig 3.3 (a) AFM image of Ag@AgO-PANI/Au nanocompiste, (b) EDX spectra of
Ag@AgO-PANI/Au

nanocompiste,

and

immunoelectrode
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(c)

BSA/Anti-Cab/Ag@AgO-PANI/Au

3.3.2 Electrochemical Characterization
The stepwise fabrication of the nanocomposite film and its functionalization for
biosensing has been studied using electrochemical impedance spectroscopy (EIS). In EIS
spectra (Nyquist plot)(Fig 3.4), the diameter of the semicircle estimates the charge
transfer resistance (RCT) which reveals the electron transfer kinetics at the electrodeelectrolyte interface and is affected by the immuno reaction occurring at electrode
interface. The Nyquist spectra of bare Au electrode exhibits a well-defined impedimetric
behavior (curve a, RCT = 120Ω) i.e., semicircle in 5mM Fe(II)/Fe(III) as redox moieties in
PBS. The obtained data was fitted using an equivalent electrical circuit (inset, Fig 3.4).
Increase in the diameter of semicircle for electrophoretically deposited PANI/Au
electrode (curve b, RCT = 220Ω) reveals that PANI film hinders the electron transport
from the redox moieties to electrode indicating the fabrication of PANI film onto Au
electrode. After the incorporation of Ag@AgO nanoparticles in PANI backbone, the
diameter of the semicircle decreased (curve c, RCT = 175Ω) revealing that the core shell
nanoparticles enhanced the electron transport in the nanocomposite. This may be due to
the uniformly distributed cationic AgO (IEP ~ 10.4) in PANI backbone, which helps to
increases the adsorption of redox moieties and to channelize the electron transport
phenomena. The value of RCT was found to increase (curve d, 280Ω) after the
immobilization of Anti-Cab onto Ag@AgO-PANI/Au electrode. This suggests that the
insulating nature of Anti-Cab hinders the electron transport from electrolyte to electrode
indicative of successful immobilization of Anti-Cab onto nanocomposite surface via
covalent binding with PANI and electrostatic interactions with Ag@AgO. Further
increment in RCT value (curve d, 400Ω) after the immobilization of BSA is attributed to
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blocking of non-binding cites of Ant-Cab/Ag@AgO-PANI/Au nanocomposite electrode,
resulting in reduction of electron transport flow and binding on BSA protein molecules.
EIS measurements were repeated in triplet and obtained results were found to be
repeatable.

200

a = Au electrode
Rs
b = PANI/Au electrode
c = Ag@AgO-PANI/Au electrode
d = Anti-Cab/Ag@AgO-PANI/Au bioelectrode
e = BSA/Anti-Cab/Ag@AgO-PANI/Au bioelectrode
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Fig 3.4 Characterization of stepwise fabrication of nanocomposite and immunosensor
using EIS in PBS (10 nM, pH = 7, 0.9%NaCl) containing 5 mM Fe(II)/Fe(III) redox
moieties.
Cyclic voltammetry (CV, Fig 3.5) was also used to study the electro activity of the
functionalized electrode to understand the electrochemical behavior of the electrode
during the step-wise fabrication process. Bare Au electrode (inset a, Fig 3.5) exhibited
oxidation and reduction current magnitude in the range of ~10-9 A which is typical for
bare Au electrode. Electrophoretically deposited PANI/Au electrode exhibited well
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defined oxidation (0.1 V) and reduction (-0.1V) with increase in the magnitude of
oxidation current response to 2 x10-4 A due to the oxidation of emaraldine base form of
PANI. The magnitude of oxidation response current for Ag@AgO-PANI nanocomposite
increases two fold to 4x10-4A in comparison to pure PANI. This suggests that
incorporation of core-shell Ag@AgO nanopaprticles in PANI accelerates the electron
transfer between electrons generated via oxidation of PANI to the electrode. The obtained
well resolved sharp peak of Ag@AgO-PANI nanocomposite with amplified current value
is due to the coordination between PANI and core-shell Ag@AgO nanoparticles.
Ag@AgO nanoparticles also contribute in electron transport along with PANI through
charge hopping via metallic conductors that result in enhanced charge transport via
PANI. It is observed that doping or incorporation of electro-active metal/metal oxide ions
in conductive polymeric backbone increases the effective surface and produces improved
charge carriers per unit volume. In our system, the core-shell nanoparticles bind with the
amine group of PANI (protonation) and the resulting nanocomposite become polarinic,
wherein spin and charge are delocalized in the system. In Ag@AgO-PANI
nanocomposites, the establishment of a polarons-bipolarons equilibrium results in
enhanced mobility of charge carriers for the charge transport leading to increased charge
density (curve c). In electrochemical reaction, the resistance to electron conduction is
high in case of PANI and Au substrate; this may be due to some defects in PANI film.
However, in nanocomposites, the presence of core-shell Ag@AgO nanoparticle in PANI
backbone decreases the resistance and channelizes the electron transport revealing the
enhanced charge density that result in fast electron transport via nanocomposite to
substrate.
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The magnitude of the electrochemical current response decreases to 2.5x10-4A after
the immobilization of Anti-Cab onto Ag@AgO-PANI/Au nanocomposite electrode
indicating the binding of Anti-Cab (curve d). The decreased current response is due to
hindrance in electron transport caused by the insulating antibodies. Furthermore, the
magnitude of current response of BSA/Anti-Cab/Ag@AgO-PANI/Au immunoelectrode is
observed to be lower than that of Anti-Cab/Ag@AgO-PANI/Au electrode (curve e).
Decrease in current is attributed to the hindrance in charge transformation due to the
insulating behavior of BSA via blocking of non-specific binding cites.
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Fig 3.5 Characterization of stepwise fabrication of nanocomposite and immunosensor
using CV in PBS (10 nM, pH = 7, 0.9%NaCl); inset: CV of bare Au electrode.
The sensing performance is dependent on electrochemical responsiveness of the
immobilizing matrix and antibodies. In immunosensors, the net charge and activity of
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amino acids available on antibody is responsible for antigen-antibody binding. Also,
during immobilization, the proteins may lead to rearrangement and conformational
changes in native structure. These features of antibody are found to be electrolyte pH
dependent and thus need to be optimized. It was observed that the magnitude of
electrochemical response current of BSA/Anti-Cab/Ag@AgO-PANI/Au immunoelectrode
decreases on increasing pH from 6.0 to 8.0 (Fig 3.6; inset a). The magnitude of current
response decreases gradually, and at pH 8, immuno-electrode lost electrochemical
activity due to highly basic medium. Similarly the magnitude of response current for
Ag@AgO-PANI/Au electrode (Fig 3.6; inset b) decreases on increasing pH value due to
de-protonation effect. Although current response values for Ag@AgO-PANI/Au and
BSA/Anti-Cab/Ag@AgO-PANI/Au were found to be better at pH values 6.0 and 6.5, but
the immunosensor response toward cortisol was found better at pH 7.0. Thus, pH 7.0 was
designated as the optimized working electrolyte pH. Further, at pH 7.0 electrolyte
behaviors is adjacent to the neutral media, wherein, due to physiological condition
electrolyte mimics biological condition. Moreover, the electrodes showed repeatable and
reproducible electrochemical response behavior at pH 7.0.
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Fig 3.6 CV studies of immunoelectrode as a function of pH (6.0 to 8.0); inset: (a)
magnitude of current v/s pH for BSA/Anti-Cab/Ag@AgO-PANI/Au immunoelectrode;
(b) CV studies of Ag@AgO-PANI/Au nanocomposite electrode.

The effect of scan rate (10 to 100mV/s) on the electrochemical behavior of
Ag@AgO-PANI/Au nanocomposite electrode and BSA/Anti-Cab/Ag@AgO-PANI/Au
immunoelectrode was studied and is presented in Fig 3.7 and Fig 3.8. The magnitude of
electrochemical response current [cathodic (Ip) and anodic (Ic)] for both electrodes are
linearly dependent on the scan rate and follows equations 1-4. The observed well-defined
stable redox peaks as a function of scan rate suggests that it is a surface-controlled
electrochemical process and diffusion of electrons on surface is taking place in a
controlled

manner.

The

consistent

peak-to-peak
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separation

and

stable

peak

position/current during repetition at constant scan rate was repeatable and indicate that
nanocomposite electrode exhibits quasi-reversible process. The obtained sharp wellresolved peaks at higher scan rate without mediator suggest that Ag@AgO-PANI
nanocomposite is electrochemically very active and is suitable for fabricating mediator
free electrochemical biosensors. Moreover, the magnitude of both cathodic (Ep) and
anodic peak (Ec) potentials for both nanocomposite electrode and immunoelectrode
increases linearly as function of scan rate (equations 5-8) reveals the electron transport
form redox moieties to the electrode is very feasible.
Ip(A)Ag@AgO-PANI = -9.01x10-5A + 5.82 x10-5A(s/mV) x Scan rate (mV/s) with SD =
3.7x10-6 and r2 =0.999……………………..…..1
Ic(A)Ag@AgO-PANI = 6.82x10-5 - 5.25 x10-5 A(s/mV) x Scan rate (mV/s) with SD = 3.72x10-6
and r2 =0.999…………………….……2
Ip(A)BSA/Anti-Cab/Ag@AgO-PANI = 5.97x10-5 (A)+ 1.47 x10-4 A (s/mV) x Scan rate (mV/s) with
SD = 3.01x10-4 and r2 =0.999…………3
Ic(A)BSA/Anti-Cab/Ag@AgO-PANI = 1.1x10-4 (A) - 1.29 x10-4 A (s/mV) x Scan rate (mV/s) with SD
= 2.28x10-5 and r2 =0.999…………..4
Ea(V)Ag@AgO-PANI = 0.045V+3.12x10-4 (s) x Scan rate (mV/s) with SD= 0.0026,and r2 =
0.97…………………………………………5
Ec(V)Ag@AgO-PANI =- 0.048 V-3.6x10-4(s) x Scan rate (mV/s) with SD = 0.0025,and r2 =
0.97…………………………………………..6
Ep(V)BSA/Anti-Cab/Ag@AgO-PANI = 0.07 V+6.2x10-4(s) x Scan rate (mV/s) with SD= 0.47, and
r2 = 0.97…………………………………...7
Ec(V)BSA/Anti-Cab/Ag@AgO-PANI =- 0.05 V+0.0012 (s) x Scan rate (mV/s) with SD = 0.0017,
and r2 = 0.99………………………………8
The surface concentrations of redox species on PANI /Au electrode, Ag@AgOPANI/Au electrode and BSA/Anti-Cab/Ag@AgO-PANI/Au immunoelectrodes have been
estimated using ip = 0.227nFACo* ko exp[-α na F/RT x (Ep-Eo!)], where ip is the anodic
peak current, n is the number of electrons transferred (2), F is the Faraday constant
(96485.34 C mol-1), A is surface area (0.25 cm2), R is the gas constant (8.314 J mol-1 K-

97

1

), Co* is surface concentration of the ionic species of electrode surface (mol cm-2), Ep is

the peak potential and Eo! is the formal potential.–αnaF/RT and ko (rate constant (0.5)),
correspond to the slope and intercept of ln (ip) verses Ep-E0! curve at different scan
rates[3].
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Fig 3.7 CV studies of Ag@AgO-PANI/Au electrode as a function of scan rate (10100mV/s); inset: (a) magnitude of current response v/s square root of scan rate; (b) Redox
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The surface concentration of redox species on Ag@AgO-PANI/Au electrode surface
is found to be higher than PANI electrode revealing that the interaction of core-shell
Ag@AgO nanoparticle with multi-charged aromatic structured PANI help to uncoil
PANI to form open conformation that results in increased electro-active surface area.
This suggests that larger numbers of redox species adsorb onto nanocomposite electrode
and contribute to the higher faradic current due to open conformation. The value of
cathodic response current is almost equal to the anodic response current value. The
variation of just ~0.05 µA confirms the reversible stable electrochemical behavior of
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nanocomposite. This is due to the presence of core-shell Ag@AgO nanoparticles in PANI
matrix as a dopant that stabilize electrochemistry and leads to the steady and reversible
behavior of Ag@AgO-PANI nanocomposite. However, the value of surface
concentration of redox moieties decreases for BSA/Anti-Cab/Ag@AgO-PANI/Au
immunoelectrode due to the blocking of the electro-active cites via BSA.
The heterogeneous electron transfer rate constant (ks) for BSA/Anti-Cab/Ag@AgOPANI/Au immunoelectrode was estimated as 5.2 s-1 using the Laviron model as ks
=mnFv /RT, where m is peak-to-peak separation, F is Faraday constant, v is scan rate
(mV/s), n is the number of transferred electrons and R is gas constant[15]. The obtained
ks value (T=298K, n=2 m= 0.103V and v = 100mV) is similar to other highly electroactive nanoparticles based bioelectrodes indicating fast electron transfer between
immobilized biomolecules and electrode [15-17].

3.3.3 Electrochemical response study for cortisol detection
The

electrochemical

response

current

of

BSA/Anti-Cab/Ag@AgO-PANI/Au

immunoelectrode has been studies using CV technique in triplet set using PBS (pH 7
containing 0.9%NaCl) at scan rate 30 mV/s as a function of cortisol concentration
ranging from 1pM to 1 µM. All immunoelectrodes were fabricated in identical condition
and exhibit current value with a maximum variation of 3%. Fig 3.9 depicts that the
magnitude of electrochemical current response decreases as a function of increasing
cortisol concentration at an incubation time of 30 min. This is due to the formation of
insulating immunocomplex formed between antibody and cortisol that hinders electron
transport. A calibration curve between the magnitude of current response and logarithm
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of cortisol concentration has been plotted (inset, Fig 3.9), which reveals a linear
correlation up to 1 µM and follow the equation Ia(A) = -3.53x10-4A M -66 µA x
Log[cortisol conc.(M)] with SD = 9.01x10-6. The immunosensor exhibited a linear
detection range from 1pM to 1 µM at a sensitivity of 66µA M-1 (higher than ELISA) with
a regression coefficient of 0.998. The detection limit of the fabricated BSA/AntiCab/Ag@AgO-PANI/Au immunosensor is estimated as 0.64 pM using 3δb/m, where m is
the slope of the calibration graph and δb is the standard deviation of the baseline signal.
The obtained detection limit is lower than ELISA technique and other immunosensors
reported in literature.
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Fig 3.9 Electrochemical response studies of BSA/Anti-Cab/Ag@AgO-PANI/Au
immunoelectrode as function of cortisol concentration (1pM to 1μM) using PBS (pH 6.5,
0.9% NaCl); inset: calibration curve between magnitude of response current and
logarithm of cortisol concentration.
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3.4 Conclusion
The first research activity undertaken was to establish an immunosensing platform for
the electrochemical detection of cortisol. A nanostructured immunosensing platform
based on a hybrid nanocomposite film of core-shell Ag@AgO nanoparticles and
Polyanaline (PANI) has been synthesized using electrophoretic deposition (EPD) onto Au
substrate. The core-shell Ag@AgO nanoparticle (~5 nm) has successfully been
embedded in PANI backbone to make a highly electro-active Ag@AgO-PANI
nanocomposite. For the first time, the electrophoretically deposited nanomaterial was
utilized for the immobilization of monoclonal Anti-Cab to fabricate a label-free and
mediator free electrochemical immunosensor for cortisol detection. Results of
electrochemical characterization suggest that Ag@AgO nanoparticle act as doping agents
for PANI and result in the increase charge density and stabilize electrochemical behavior,
resulting in enhanced charge transfer from redox moieties to electrode. This increased
electro-active platform with nano-porous morphology and functionality provides a
friendly environment to immobilize Anti-Cab. The immunosensor was tested as a function
of cortisol concentrations in phosphate buffer saline (PBS) using cyclic voltammetry and
found to exhibit a detection limit of 0.64pg mL-1 (estimated using 3σ formula), a linear
range from 1pM to 1μM , with a sensitivity of 66μA/M.
The ultimate goal of this research is to develop a point-of-care immunosensing
platform for the detection of cortisol. The next logical step was to integrate the
immunosensing platform onto a micromachined co-planar electrode set-up. The
developed Ag@AgO-PANI based immunosensor was unable to be successfully
integrated onto microfabricated electrodes due to a high degree of non-specific
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electrophoretic deposition of the hybrid nanocomposite onto the base substrate (Glass)
leading to electrical shorting of the fabricated electrodes. To overcome challenges related
to system integration, an alternate strategy, involving the use of self-assembled
monolayer as the nanomaterial was explored and is presented in the next chapter.
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CHAPTER IV
Dithiobis (succinimidylpropionte) (DTSP) Modified Interdigitated Microelectrodes
(μIDE) for Electrochemical Immunosensing of Cortisol

4.1 Self-Assembled Monolayers (SAM)
Self-assembled monolayers (SAMs) have recently come into focus due to their
potential applications to biosensors and bio-molecular electronics[1]. Self-assembled
monolayer is a layer of molecular thickness formed by self-organization of molecules in
an ordered manner by chemisorption on a solid surface[2]. SAM consists of three
identifiable parts: a surface-active head group that binds strongly to a substrate, an alkyl
chain giving stability to the assembly by van der Waals interactions, and a functional
group that plays an important role in terms of coupling of a biomolecule to a monolayer.
Through proper selection of terminal functional group, specific surface/solution
interactions (covalent, electrostatic or hydrophobic) can be exploited to immobilize
molecules at an interface. SAM functionalized with large, delicate ligands for biological
studies can be prepared either by molecules with an attached ligand or more commonly
attaching ligands to the surface of a preformed SAM[3].

The stability, uniform surface structure and relative ease of varying thickness of a
SAM make it suitable for development of biosensors. And the immobilization of
biomolecules on a SAM requires very small amount and desired analytes can be easily
detected via various transduction modes. The use of an appropriate SAM helps in
oriented and controlled immobilization of biomolecules [4]. SAM modification can result
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in development of surfaces with large/complex ligands and molecules needed for biology
and biochemistry[5]. Also modification of exposed surface of a SAM offers many
advantages such as simplicity to prepare functionalized surfaces, incorporation of
synthetically non-compatible ligands into SAMs, generation of samples with multifunctional groups sensitive to different chemistries, etc.[6]. A new strategy has been
demonstrated for specific and efficient immobilization of protein using semi-fluorinated
SAM. The study reveals that such SAMs reduce non-specific protein adsorption and
result in highly sensitive measurements with low limits of detection. The advantages of
SAMs lie in their integration with a biological recognition element for development of
biosensors [7]. For fabrication of a biosensor, immobilization of a biomolecule on a SAM
surface is an important concern. SAMs for biosensing applications can be modified by
adopting many other strategies. An effective combination of antibody–antigen specificity
with transducer in a biosensor device could provide basis for direct detection of wide
range of analytes with specificity and high sensitivity. Thus SAM-based immunosensors
have implications towards development of a highly efficient protein sensor chip. In this
research activity, SAM of Dithiobis(succinimidylpropionte) (DTSP) has been utilized to
functionalize microfabricated Au electrodes for the immobilization of Anti-Cortisol
antibodies for label-free, electrochemical detection of Cortisol.
4.2 Dithiobis (succinimidylpropionte) (DTSP)
DTSP, also referred to in literature as Lomant’s reagent is a small molecular
weight (404.42 grams/mole) molecule given by the chemical formula C14H16N2O8S2. Fig
4.1 presents a schematic illustration of the molecular assembly of DTSP. DTSP has a
disulfide bond that is readily cleavable using a reducing agent such as sodium
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Fig 4.1 Threee-dimensionaal molecularr assembly o f DTSP
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smart design of the electrode shapes and dimensions. Microfabricated planar electrodes
with well-defined electrode patterns provide the platform that is required for biosensing,
as well as convenient integration with fluidic automation set-up. Over the years, many
electrode designs have been successfully fabricated and tested for biosensing applications
[10-12]. Of these, the interdigitated electrode design (μIDE) offers many advantages. The
combination of IDE’s along with electrochemical detection techniques such as Cyclic
Voltammetry and Electrochemical Impedance Spectroscopy provides the necessary
sensitivity for the detection of low concentrations of the analyte [13-15]. The efficiency
of current collection resulting from the redox cycling increases significantly as the width
and the distance between the interdigitated electrodes decrease (Fig 4.2a).
In this dissertation, interdigitated microelectrodes have been designed and
fabricated for application in immunosensing of cortisol using electrochemical detection
techniques (Fig 4.2b). The spacing and width of the electrode fingers is designed for
5µm. This number is chosen to obtain repeatable fabrication and to maintain consistency
between the many electrode chips that are batch fabricated. The total surface area of the
interdigitated part of the working and counter electrode is 6.39 mm2. The thickness of the
electrode is designed to be 50nm of chrome and 150nm of gold

109

Fig 4.2 (a) Scchematic illu
ustration of im
mproved reddox cycling in interdigitaated
microelectrod
m
des; (b) Interrdigitated Microelectrodde design

4.4 μIDE Fab
brication Prrocess
Fig 4.3 preseents the scheematic illusttration of thhe microfabrrication proccess flow foor the
faabrication of
o the interd
digitated microelectrod
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des. The intterdigitated electrodes were
faabricated on
n a 4” glass wafer to red
duce leakage currents thhat are typiccally observved in
siilicon substrrate (Fig 4.3a). Prior to usage, the gglass wafer w
was cleanedd by rinsing in DI
water,
w
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opyl Alcoholl, Acetone, Methanol
M
annd DI water in the orderr mentionedd. The
clleaned wafeer was blow dried and a dehydrationn bake was carried out on in an ovven at
100ºC for 10 minutes to remove any
y residual w
water molecuules. A thin layer of neggative
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PY-3000) was
w spin coaated (Laurelll Technologgies) onto thhe glass waffer at
3000 rpm forr 40 secondss to obtain a film thicknness of 6µm
m (Fig 4.3b). The photooresist
fiilm was softt baked at 15
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he photoresiist using con
ntact photollithography (EVG Grouup). The expposed photooresist
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was post-exposure baked at 100ºC for 60 seconds followed by developing in the
appropriate developing solution (Fig 4.3c) to realize the features. Next, the metallization
process was carried out by deposition of Cr (20nm) as the adhesion layer, followed by Au
(150nm) using an E-beam evaporator (Fig 4.3d). The sacrificial photoresist was then
removed by a lift-off process by immersing the wafer in acetone to realize the
microelectrode pattern (Fig 4.3e). A passivation layer is then deposited by spin-coating
SU-8 onto the fabricated electrode and using a 2nd photolithography process, openings are
patterned to only expose the functional part of the electrodes and the probing pads for
connection (Fig 4.3f). The fabricated wafer is then diced to obtain the individual
electrode chips. Fig 4.4 presents a microscopic image of the microfabricated
interdigitated electrode and Fig 4.4b presents the scanning electron micrographs (SEM)
of the interdigitated electrodes.

Fig 4.3 Schematic illustration of the microfabrication process flow for fabrication of the
interdigitated microelectrodes.
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Fig 4.4 Microfabricated interdigitated electrode chip (Left); Microscopic image of the
interdigitated fingers (Right)
4.5 Fabrication of DTSP SAM
Fig 4.5 presents a schematic illustration of the process of DTSP fabrication on the
Au electrodes. Prior to fabrication, the microfabricated interdigitated gold electrodes
were immersed in freshly prepared piranha solution followed by rinsing with DI water to
clean the surface. The clean electrodes were next immersed in 2mg/ml solution of DTSP
in acetone followed by addition of Sodium borohydride to reduce the DTSP. The
electrodes were kept immersed in the DTSP solution for SAM formation. Following
SAM deposition, the DTSP-SAM/Au electrodes were rinsed with acetone and then by
water to remove any unbound DTSP molecules.
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Fig 4.5 Schematic illustration of fabrication of DTSP-SAM on Au electrode.

4.5.1 Electrochemical Characterization
Results of electrochemical studies carried out using electrochemical impedance
spectroscopy studies of the electrode and DTSP-SAM/Au electrode is presented in Fig
4.6. The Nyquist plot of bare Au electrode (curve a) shows a well-defined charge transfer
resistance (Rct) correlated to electron transfer kinetics (corresponds to semicircle), and
Warburg impedance correlated to diffusion process (straight line at 45o to the axis). The
magnitude of Rct value for DTSP/Au (2850Ω, curve b) is higher than that of the Rct
value of Au electrode (2005Ω; curve a) revealing hindrance in electron transfer caused by
the insulating nature of DTSP-SAM and also confirm the fabrication of SAM onto Au
electrode. The experimentally obtained data was simulated in an electronic equivalent
circuit (inset). Similar trends were observed with CV measurements as well and are
presented in the next section along with the biofunctionalization characterization.
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Fig 4.6 Electrochemical characterization of DTSP-SAM formation using electrochemical
impedance spectroscopy (EIS)

4.6 Functionalization of μIDE for Cortisol Detection
Next, the DTSP/Au electrode was functionalized with Anti-Cortisol antibodies.
Fig 4.7 presents a schematic illustration of the biofunctionalization of the interdigitated
microelectrodes. 10µl of Anti-cortisol antibodies (Anti-Cab) was incubated on the
DTSP/Au electrode for 2h for immobilization followed by carefully washing with PBS
(pH 7.4, 10mM) to remove any unbound antibodies. Anti-Cab bind covalently (amide
bond) via a facile reaction between amino group of antibody and reactive succinimidyl
group of the DTSP SAM surface. The NH2 group of the DTSP-SAM binds with the
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carboxyl group (Fc, terminal) of the Anti-Cab and the presence of free NH3 groups of
Anti-Cab (Fab, terminal) leads to form a strong immunocomplex with cortisol.
Ethanolamine (10µL) was immobilized for 10 min on to the Anti-Cab/DTSP/Au
bioelectrode to block unreacted succinimidyl group on DTSP. The fabricated
bioelectrodes were stored under refrigeration at 4oC when not in use.

Fig 4.7 Schematic of µIDE functionalization with Anti-Cortisol antibodies
The electrochemical behavior of the stepwise fabrication of DTSP/Au electrode
and EA/Anti-Cab/DTSP/Au immunoelectrode has been studied using cyclic voltammetry
(CV) techniques. The CV curves on the bare Au electrode (curve a), DTSP/Au electrode
(curve b), Anti-Cab/DTSP/Au immunoelectrode (curve c), and EA/Anti-Cab/DTSP/Au
immunoelectrode (curve d) have been carried out in PBS (50mM, pH 7.4 containing
5mM [Fe(CN)6]3_/4_) as shown in Fig 4.8.
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Fig 4.8 The CV curves on the bare Au electrode (curve a), DTSP/Au electrode (curve b),
Anti-Cab/DTSP/Au

immunoelectrode

(curve

c),

and

EA/Anti-Cab/DTSP/Au

immunoelectrode (curve d) in have been carried out in PBS (50mM, pH 7.4 containing
5mM [Fe(CN)6]3_/4_).

It is observed that the Au electrode shows very well-defined oxidation and
reduction behavior of redox moieties Fe(II)/Fe(III) in the electrolyte. The magnitude of
electrochemical response current of the Au electrode was found to decrease after the
deposition of DTSP-SAM onto Au (curve b). This suggests the formation of DTSP-SAM,
and due to the insulating nature of DTSP-SAM, electron transfer from the medium to Au
electrode is hindered. After the immobilization of Anti-Cab onto the DTSP/Au electrode,
the magnitude of the electrochemical response current further decreased (Curve c). This
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suggests that successful binding of Anti-Cab further hinders the electrons transport from
medium to electrode. Furthermore, the magnitude of current response decreases after the
immobilization of EA onto the Anti-Cab/DTSP/Au (Curve d) immunoelectrode due to
blocking of non-specific binding sites of Anti-Cab that insulate the electrode and perturb
electron communication.
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Fig 4.9 Electrochemical optimization as a function of pH
CV studies have also been carried out to optimize the pH of PBS solution for
electrochemical measurements (Fig 4.9). The magnitude of current response is pH
dependent and maximum current response is observed at pH 7.4. Thus, PBS of pH 7.4
has been used for electrochemical studies, which is the recommended pH to get immuno
complex of high biological activity.
CV studies of DTSP/Au electrode (Fig 4.10a) and Anti-Cab/DTSP/Au immuno
electrode (Fig 4.10b) were also carried out as a function of scan rate (20–200 mV/s). The
magnitude of electrochemical current response and potential of both the electrodes are
found linearly dependent to square root of scan rate and scan rate respectively revealing
that diffusion of electrons onto electrode is a controlled process with facile electron
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transport. The surface concentration of redox moieties onto DTSP/Au and AntiCab/DTSP/Au immunoelectrode have been estimated as 3 x10-6 mol/cm2 and 1.5x 10-6
mol/cm2, respectively using the Laviron equation. This suggests that larger numbers of
redox moieties are available at the surface of DTSP/Au electrode for oxidation leading to
a higher faradic current. This leads us to believe that uniformly distributed SAM provides
an electronically operational surface for the immobilization of Anti-Cab through amide
binding.
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Fig.10. a) CV studies of DTSP/Au electrode as a function of scan rate (20-200
mV/s); inset a) magnitude of current response as a function of square root of scan rate,
inset b) potential difference versus scan rate.

b) CV studies of Anti-Cab/DTSP/Au

immunoelectrode as a function of scan rate (20-200 mV/s); inset a) magnitude of current
response as a function of square root of scan rate; inset b) potential difference versus scan
rate.
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4.7 Electrochemical Immunosensing Studies of Cortisol
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Fig 4.11 EA/Anti-Cab/DTSP/Au electrode incubated with 10µL of 200nM Cortisol.
Prior to carrying out sensing measurement, incubation time for complete binding
between Cortisol and Anti-Cab has been optimized using CV (Fig 4.11). The magnitude
of response current is dependent on electron transfer kinetics; hence to obtain a consistent
and precise response current, the optimization of incubation time is necessary. CV
measurements were performed at intervals of 10 minutes after incubation. The magnitude
of response current decreases upon increasing the incubation time due to increased
binding between Cortisol and Anti-Cab, resulting in increased electron transfer
resistance. A consistent response current was obtained after incubation time of 30 min.
This time is consistent with literature reported for antigen-antibody binding kinetics,
which suggests that more than 80% of the binding is completed in the first 30 minutes,
after which the binding kinetics are minimal.
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The electrochemical response of EA/Anti-Cab/DTSP/Au immunoelectrode (Fig
4.12a) has been studied as a function of cortisol concentration (10 pM to 200 nM) using
CV technique under identical experimental conditions (PBS (10 mM, pH 7.4) containing
5mM Fe(CN)63-/4- as a redox probe and potential ranging from -0.6V to +0.6V).

-4

3.2x10

-4

2.4x10

-4

Current (A)

1.6x10

-5

8.0x10

a = 0.0 M
b = 10.0 pM
c = 50.0 pM
d = 100.0 pM
e = 1.0 nM
f = 10.0 nM
g = 100.0 nM
h = 200.0 nM

a

h

0.0
-5

-8.0x10

-4

-1.6x10

-4

-2.4x10

-0.4

-0.2

0.0

0.2

Potential (A)

121

0.4

0.6

-6

2.8x10

-6

Current (A)

2.6x10

-6

2.4x10

-6

2.2x10

-6

2.0x10

-6

1.8x10

1E-11

1E-10

1E-9

1E-8

1E-7

Log [cortisol Concentration (M)]
Figure

4.12

(a)

Electrochemical

response

studies

of

EA/Anti-Cab/DTSP/Au

immunoelectrode as a function of cortisol concentration (10pM to 200nM); (b)
Calibration curve between magnitude of response current and log [cortisol concentration
(M)].

It is can be seen from Fig 4.12a that the electrochemical response current
decreases with increasing cortisol concentrations (10 pM-200 nM). This is due to the
formation of immuno complexes between Anti-Cab and cortisol resulting in electron
charge transfer hindrance at the electrode electrolyte interface. The magnitude of
electrochemical response current of EA/Anti-Cab/DTSP/Au immunoelectrode is linearly
dependent to the logarithm of cortisol concentration (Fig 4.12b) and obeys the relation Y

122

= A (4.4x10-5) – 2.07 10-5 x log (Cortisol Concentration); R = 0.997. The EA/AntiCab/DTSP/Au immunoelectrode exhibits linear range from 10pM to 200nM, at a
detection limit of 10pM and sensitivity of 20.7µA M-1 with a correlation coefficient of
0.997 (SD: 0.78µA). The value of the association constant (Ka) was estimated at 9×1011
L/mol indicating strong affinity of Anti-Cab with cortisol attributed to the immobilization
of Anti-Cab onto the DTSP/Au electrode in the desired orientation. To determine the
specificity of the immunosensor towards Cortisol and the effect of non-specific
adsorption, electrochemical response was measured in the presence of other commonly
present antigens. The EA/Anti-Cab/DTSP/Au immunoelectrode showed a minimum
change in electrochemical response in the presence of PSA (200nM), EGFR (200nM) and
NSE (200nM). However, a significant change in electrochemical response was obtained
for cortisol (200nM) and Cortisol mixed with BSA (150nM Cortisol + 50nM BSA),
confirming that immunoelectrode is specific to Cortisol with minimal signal from nonspecific antigens.
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Fig 4.13 Percentage change in electrochemical response of the EA/Anti-Cab/DTSP/Au
immunoelectrode after incubation with PSA (200nM), EGFR (200nM), NSE (200nM),
Cortisol (200nM) and Cortisol mixed with BSA (150nM Cortisol + 50nM BSA).

4.8 Cortisol Detection in Saliva Samples
The

developed

DTSP

self-assembled

monolayer

based

electrochemical

immunosensor for cortisol sensing was utilized for testing of cortisol concentrations in
saliva samples. Saliva samples were obtained from Mexican immigrant farm workers in
collaboration with Dr. Shedra Amy Snipes, assistant professor of behavioral health,
Pennsylvania State University, who utilizes the saliva sample to detect cortisol
concentrations and correlate it to organophosphate exposure to farm workers in the field.
The saliva samples were de-identified by stripping out all identifiers such as name, age,
gender, etc. related to the source of the saliva samples. Normal values of cortisol
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concentration at different time zones, as defined by Mayo medical diagnostics, during a
24-hour time period is presented in Table 4.1.
Time Zone

Normal Cortisol Concentration (ng/dL)

5 a.m.-10 a.m.

100-750

3 p.m.-5 p.m.

<401

11 p.m.-midnight

<100

Table 4.1 Normal cortisol concentrations as defined by Mayo medical diagnostics.
The saliva samples were collected at two separate time period in a 24-hour span
over three days using special saliva collection devices called salivettes. The obtained
salivettes were stored at -20C until used. Prior to usage, the saliva samples were
defreezed to room temperature and centrifuged for 15 minutes at 3500rpm to harvest the
saliva from the salivette. To perform the electrochemical detection, 10µL of the saliva
sample was incubated on the electrochemical immunosensor for a period of 30 minutes.
A washing step using 30uL of PBS was performed to remove the saliva and any unbound
cortisol from the sensor surface. Electrochemical response studies were carried out using
cyclic voltammetry in 10µL of PBS containing 5mM Fe(II)/ Fe(III) as the redox probe.
All samples were measured in triplicate sets and the average was computed and is
presented in Table 4.2. The standard curve obtained from known concentrations of
cortisol was then used to determine the concentration of cortisol in the saliva samples.
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Specimen

Saliva Collection
Time and Date

Measured
Cortisol
Final Cortisol
Electrochemical Concentration Concentration
Response (µA)
(Obtained
(ng/dL)
Concn. x 2.2)
(nMol/L)
3/26/2013 (9:47AM
P137
7.16
3.63
131.78
3/27/2013 (10AM)
7.38
3.81
138.37
3/27/2013 (10:03P
12.23
0.90
32.94
3/28/2013 (2AM)
8.89
1.818
65.89
3/26/2013 (10:13AM)
P138
5.24
9.09
329.45
3/27/2013 (1:42AM
7.76
2.727
98.83
3/27/2013 (10:13A)
4.26
14.54
428.29
3/28/2013 (3:02AM
9.17
1.93
69.18
Table 4.2 Cortisol values measured in saliva samples using the developed
electrochemical immunosensor

To validate the results obtained from the electrochemical immunosensor, saliva samples
from the same salivette were tested for cortisol using ELISA (Arbor Assays, MI), the
current gold standard for measuring cortisol concentrations in saliva samples. The
protocol prescribed by the ELISA kit vendor was followed for cortisol detection in saliva
samples. To establish the calibration curve for cortisol measurement, the assay was
performed in a 96-well titer plate consisting of six known standard cortisol concentrations
(100, 200, 400, 800, 1600 and 3200 pg/mL) and the saliva samples. The calibration curve
obtained from the measurement of the standard solutions is presented in Fig 4.14. Next,
the saliva samples were diluted 1:4 in the provided assay buffer and 50uL of saliva
samples were utilized for each measurement. Saliva samples from each of the salivettes
were tested in triplicate sets and the average value was utilized to determine the final
cortisol concentration and is presented in Table 4.3.
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Fig 4.14 The standard cu
urve obtained for determ
mination of tthe cortisol concentratioons in
saaliva samplees using ELISA.
Cortisol
Final C
Cortisol
Cooncentration
Concentration
(pg/mL)
(ngg/dL)
4X
X dilution
3/26/2013
3
(9:47AM
P137
64.133
389
1555.6
3/27/2013
3
(10AM)
66.909
360
144
3/27/2013
3
(10
0:03P)
56.113
594
2337.6
3/28/2013 (2
2AM)
81.758
182
722.8
3//26/2013 (10::13AM)
P138
41.705
995
398
3//27/2013 (1:4
42AM)
99.559
125
550
3/27/2013
3
(10
0:13A)
40.956
1187
4774.8
3//28/2013 (3:0
02AM)
96.695
87
344.8
Table
T
4.3 Co
ortisol valuess measured in saliva saamples usingg the commeercially avaiilable
Sample
S

Saliva
S
Collection
D
Time and Date

Measured
M
Ressponse
(4x dilutioon)
(%B/Bo))

Cortisol
C
ELIS
SA kit.
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Fig 4.14 (a) and Fig 4.14 (b
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with
w
that ob
btained from
m ELISA, except
e
for tthe saliva ssample from
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(3
3/27/2013 (1
10:03P)), in which
w
the ELISA
E
value was observeed to be a hiigh value at night
tiime. It was observed th
hat the obtained values from the eleectrochemiccal measurem
ments
were
w
consisteent with the trend obserrved from thhe ELISA m
measurementts, however at an
off-set. Hencce, all valuees of cortisol concentrration obtainned from thhe corresponnding
caalibration cu
urve were corrected
c
by
y a factor oof 2.2 in ordder to comppare with vvalues
ob
btained from
m ELISA assays. A goo
od correlationn was obserrved between the two seets of
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data, thus enabling quantitative validation of the electrochemical immunosensing of
Cortisol in a biologically relevant fluid such as saliva.

4.9 Conclusion
The research activity undertaken was to develop a DTSP-SAM based
electrochemical immunosensing platform for the detection of cortisol. The DTSP-SAM
was

modified

onto

microfabricated

interdigitated

microelectrodes

(µIDE).

Electrochemical characterization of the DTSP-SAM modification and fabrication of the
immunoelectrode is presented. The immunosensor was tested as a function of cortisol
concentrations in phosphate buffer saline (PBS) using cyclic voltammetry and found to
exhibit a detection limit of 10pM, a linear range from 10pM to 200nM, with a sensitivity
of 20.7µA M-1. The next research activity planned was to automate the electrochemical
immunoassay as a step towards realizing a fully automated point-of-care cortisol sensor.
The next chapter details the efforts to integrate the developed DTSP-SAM based cortisol
immunosensor on the µIDE’s into a low-cost, disposable microfluidic system.
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CHAPTER V
Low Temperature Co-fired Ceramics (LTCC) Based Microfluidic System for
Automation of Cortisol Immunoassay

In this chapter, the design, fabrication and fluidic characterization of LTCC based
microfluidic system is presented. The optimization of the microfluidic system design for
the automation of the immunoassay has been done using a computational fluid dynamic
approach. A novel approach using LTCC technology has been applied for the fabricating
a microfluidic system. For the first time, the non-specific adsorption (NSA) of a
biomolecule (Cortisol) on LTCC surface has been characterized as part of the
microfluidic system design and development.

5.1 Non-Specific Adsorption (NSA) of Cortisol on LTCC
Advantages such as rapid prototyping, 3D architecture, and cost effective
fabrication have made LTCC an attractive alternative to polymer, silicon and glass based
microfluidics. With a steady increase in the application of LTCC microfluidic systems for
sensing of biomolecules, a thorough characterization of LTCC as a material for biomicrofluidic systems is imperative. An important material property that is taken into
account during microfluidic device development is the biocompatibility of the utilized
materials that interact with the bio-analyte[1]. The term biocompatibility, in general,
encompasses several features such as host-tissue response, immune and inflammatory
response, toxicity etc., which are however more pertaining to in-vivo scenarios. For invitro applications, biocompatibility is measured by factors such as facilitation of cell
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cultures in scaffold materials for tissue engineering, material disintegration during
material-fluid interaction, and the non-specific adsorption of proteins, enzymes, DNA
and other biomolecules onto the material surface.
To assess the biocompatibility of LTCC, Smetana et al. [2] have reported the
characterization of cell proliferation of various cell lines (HeLa cells, BAC cells and
L929 cells) on three commercially available LTCC materials in both the fired as well as
green state. The results indicate that apart from the CeramTec tapes, all other LTCC tapes
showed cell proliferation comparable to the control (glass). Cell culture chambers in
LTCC microfluidic devices are often integrated with electronic sensors and actuators,
typically achieved through screen-printed metals. Hence, the understanding of the effect
of metal compositions on cellular responses is imperative for design considerations.
During the process of development of LTCC based flow sensor for biological
applications, Torres et al. [3] have reported the investigation of cell culture growth
(mammalian cell lines HEK 293 FT and CHO-k1) on LTCC substrates. Cellular response
studies were carried out on both LTCC blank substrates (DuPont 951) as well as screenprinted metal compositions (DuPont Au, Pt, Ag). Additionally PCR experiments were
also carried out in the presence of LTCC blanks and the screen print metal compositions.
The results indicate that the LTCC blanks provide a congenial surface for cellular
activities; however, a negative cellular response was observed on the screen-printed metal
compositions. Leachates from the metal have been singled out as the reason for the
detrimental effects on cell cultures. Recently, Mercke et al. [4] have evaluated the
viability of culturing HUVEC (Human Umbilical Vein Endothelial Cells) on Heralock®
HL2000 tapes along with their recommended screen printed Au and Ag paste. While their
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results indicate difficulty in initial attachment of the cells onto the LTCC substrate, no
negative response was observed for cells cultured on the screen-printed films of Au and
Ag. The cell cultures showed good viability up to three days. Recently, Zhang et al[5]
have reported a thorough characterization of the biostability of LTCC material for
biomedical and microfluidic device applications. Leaching rate studies of three
commercially available green tape materials have been studied during LTCC interaction
with relevant fluids such as phosphate buffer saline (PBS), simulated body fluid (SBF),
simulated gastric fluid (SGF), and a basic solution (1M NaOH solution, no physiological
analogue). Leaching rate of LTCC in these fluids has been determined through weight
loss and elemental analysis. The reported results suggest that techniques such as surface
passivation, flushing out of leached material and diffusion limited leaching may be
required depending on the LTCC-fluid exposure time.
When microfluidic devices are used for biosensing applications, a factor of
importance is the interaction of the analyte with the surface of the microchannels and the
assay chamber. A common phenomenon that is observed is the rapid adsorption of
biomolecules (analyte) on the surface of the device[6]. This phenomenon, referred to as
non-specific adsorption (NSA), can lead to loss of analyte concentration via adsorption
on to the surface leading to erroneous results[7]. An understanding of NSA is especially
important in microfluidic biosensors which involve incubation steps for considerable
lengths of time. The NSA of biomolecules is commonly observed in microfluidic systems
fabricated from PDMS[6], PMMA[8], Silicon[9] and Glass[10]. Information obtained
from NSA studies is used to develop surface modification techniques to reduce NSA.
Many surface pretreatment strategies such as coating, plasma exposure, hydrophobic
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tuning and decreasing surface charge are well characterized to reduce non-specific
adsorption on microfluidic materials such as silicon, glass, and polymers[11].
With increasing application of LTCC based microfluidic systems for biosensing
applications, the characterization of NSA of biomolecules on LTCC has become
essential.
5.1.1 Design of Experiment, Materials and Methods
All the characterization has been performed on DuPont 951 LTCC tapes. The
unfired samples were used as received and the fired LTCC samples were obtained by
sintering the samples in an oxygen rich furnace to 850ºC at a temperature ramp profile as
shown in Fig. 1. Scanning electron microscopy (SEM) was performed on unfired and
fired LTCC tapes using a tabletop SEM (Phenom, Netherlands).

1mm

Fig 5.1 LTCC 32 micro-well plate fabricated for the NSA characterization.
X-Ray Diffraction (XRD) analysis was performed on the LTCC samples using a
Siemens Diffraktometer. The X-ray patterns were measured from 2theta ranging from 10º
to 70º at a rate of 2 deg/min. For XRD analysis performed on Cortisol incubated LTCC
samples, 50µL of Cortisol solution of 500nM concentration in PBS was incubated on
fired LTCC samples for a period of 1 hour and allowed to dry at room temperature
(unwashed). Contact angle measurements were performed using a contact angle
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goniometer (ramé-hart, NJ) using 0.5µL of DI water (surface tension: 72 dyn/cm) as the
test liquid.
For the quantitative analysis of non-specific adsorption of cortisol on LTCC,
Enzyme-Linked Immunosorbent Assay (ELISA) has been utilized. 5µL of two prepared
concentrations of Cortisol in phosphate buffer saline (1µM and 500nM) were pipetted on
to LTCC surface and incubated for increasing time periods. After specific time periods
the solution was removed and cortisol concentration assays were performed using
commercially available Cortisol ELISA kits (Arbor Assays, Michigan). The
concentration of residual Cortisol in the solution was used to quantify the amount of
NSA. To reduce variability due to sample preparation and testing conditions, adsorption
studies were carried out in 32-well plates (Fig 5.2), fabricated on a 4cm x 6cm substrate
using standard LTCC processing techniques. The adsorption tests were run in duplicates
and the ELISA tests were further run in triplicates. The volume in each well was designed
for 10µL by optimizing the number of LTCC layers.
5.1.2 Results and Discussion

(b)

(a)

Fig 5.2 Scanning electron microscope images of the DuPont 951 LTCC green tapes in the
(a) Unfired and (b) Fired state.
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Fig 5.2 presents the SEM images of the DuPont 951 LTCC tapes in the green (Fig
5.2a) and the fired state (Fig 5.2b). The highly granular structure visible in the green state
represents the micro particles of Alumina and glass suspended in an organic matrix. It
can be seen that the morphology of the surface changes to a much less abrasive
appearance in the fired tapes due to the burnout of the organic components and the
encapsulation of the ceramic granules with the melted glass. This was validated through
characterization of the surface roughness of the unfired and fired LTCC substrates. Fig
5.3 (a, b) presents the surface profile of the unfired and fired LTCC tapes using a stylus
tip surface profilometer. The average surface roughness of the unfired and fired LTCC
tapes was found to be 450±3nm and 307±3nm respectively. To understand the effect of
surface morphology on NSA several experimental investigations of NSA of proteins as a
function of surface roughness exist in literature [12-14]. However, the theory of the
kinetics of non-specific adsorption as a function of surface roughness is not known.
Therefore, based on the empirical data available, it is hypothesized that the average
surface roughness of 1nm to 5nm promotes non-specific adsorption due to a proportional
increase in surface area, as well as creation of nano-cavities and nano-clefts facilitation
capture of biomolecules. This particularly applies in this case of Cortisol, which is low
molecular weight (362 Dalton), lipophilic molecule. It is also reported that surface
roughness of higher magnitude play negligible role in NSA. In the case of LTCC, since
the average surface roughness is much greater (~102 nm) than values reported for PDMS,
Glass or Silicon, it is expected that the effect of surface roughness on NSA is negligible.
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Fig 5.3 Surface roughness profiles obtained for (a) unfired and (b) fired LTCC substrate
using a stylus tip profilometer.
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Fig 5.4 X-Ray Diffraction pattern of DuPont 951 LTCC; (a) Fired LTCC; (b) Fired
LTCC conjugated with Cortisol.
To characterize the chemical composition of the surface, XRD analysis was
performed on fired LTCC samples (Fig 5.4a) and on fired LTCC samples with incubation
of Cortisol (Fig 5.4b). Only aluminum oxide peaks were visible and identified in the fired
LTCC samples. After incubation of Cortisol, an additional peak was observed (indicated
in Fig 5.4b), but the non-crystallinity of Cortisol and high background noise made it
difficult to identify the peak as that of a biomolecule such as Cortisol.
The hydrophobicity of a material is directly related to the surface composition and
surface energy of a material and is known to be a critical factor in adsorption of
biomolecules on a material. Contact angle measurement is a popular technique to
characterize adsorption of biomolecules on a surface resulting in increased
hydrophobicity[15]. The wetting angle recorded on fired LTCC surface was 26º ± 3º,
indicating an intrinsically hydrophilic, high surface energy surface. It is a wellcharacterized phenomenon that protein adsorption decreases as the surface energy of the
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material increases [16, 17]. No significant change was observed in the contact angle after
incubating 5µL of 500nM cortisol solution for a period of 60 minutes. The wetting angle
also has significance in the dynamics of fluid flow in microchannels, and hydrophobicity
of LTCC increases the prospects of capillary driven flow in LTCC based microfluidic
systems.
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Fig 5.5 (a) ELISA standard curve for cortisol concentration; (b) Picture of the 96 well
micro-titer plate after completion of the ELISA assay; (c) % NSA of 1µM (-■-) and
500nM (-▲-) cortisol solutions incubated on LTCC as a function of incubation time.
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Fig 5.5 presents the percentage non-specific adsorption of cortisol for 1µM (-■-)
and 500nM (-▲-) cortisol solutions incubated on LTCC as a function of incubation time.
10µL of 1µM and 500nM cortisol solution was incubated in individual wells in the
fabricated LTCC micro-well plate (Fig 5.1). At specific time intervals, the cortisol
solution was aspirated from the well and the concentration of cortisol was quantified
using ELISA. Fig 5.5a presents the standard curve obtained from the ELISA kit. Cortisol
concentrations from the NSA study were deduced from this standard curve. Fig 5.5b
presents an image of the 96 well micro-titer plate after completion of the ELISA assay. A
rapid adsorption of cortisol on LTCC was observed between 5 to 15 minutes, followed by
saturation of non-specific adsorption. This effect was more pronounced in the higher
concentration (1µM) compared to the lower concentration (500nM). This may be
attributed to concentration dependent kinetics of protein adsorption to reach equilibrium.
The adsorption of cortisol was seen to remain constant at around 12% of the initial
concentration for incubation times over 50 minutes. Since the physiological values of
cortisol in biofluids such as saliva is many orders of magnitude lower than 500nM and
the typical incubation times are generally under 30 minutes, the effect of non-specific
adsorption is expected to contribute minimally towards sensor performance.
In this study, properties of LTCC such as surface morphology, surface energy,
hydrophobicity and surface roughness, which are responsible for NSA have been
characterized. The results show that the NSA is concentration and time dependent. A
rapid adsorption was observed initially and a consistent adsorption was observed between
15 to 30 minutes. These finding were factored into during the design of the LTCC
microfluidic system and the immunosensing protocol.
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5.2 Microfluidic Protocol for Electrochemical Immunosensing
The sequence of operation of the microfluidic manifold to perform the immunoassay
is presented below. Fig 5.6 presents a schematic illustration of the microfluidic
system design for automation of the immunosensing assay.
1. The sample containing the analyte (cortisol) is introduced into the measurement
chamber using an inlet channel at a rate of 10µl/min using a programmable
syringe pump in the infuse mode. A volume of 10µL is required to fill the
measurement chamber and fully dispersed over the functionalized electrode. The
sample containing cortisol is allowed to incubate for 30 minutes.
2. A buffer solution of PBS containing 5mM Fe(CN)63-/4- is introduced into the
chamber at a flow rate of 10µl/min through the inlet channel. A microfluidic
valve is required to switch the inlet channel between the sample introduction
pump and the buffer introduction pump. The buffer solution is allowed to flow
through the chamber for three minutes (30µL) until the electrode has been washed
of all non-specific entities on the surface of the electrode. The buffer and sample
exit the chamber through the outlet channel that connects to a waste reservoir.
3. After the washing process, the outlet is closed and 10µL of the buffer solution is
allowed to fill the measurement chamber. At this point, all the inlets and outlets
are closed and the electrochemical response of the immunoelectrode is measured
using a connected Potentiostat.
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incompressible Navier-Stokes flow. A no-slip condition was assumed along the walls of
the microchannel and physical values of water (dynamic viscosity: 0.89cP; density:
1,000kg/m3) were used in the numerical computation. The effect of the position of the
inlet and outlet microchannels on the flow profile and the geometry of the assay chamber
were investigated. A constant flow rate (10µl/min) was applied across the cross-section
of inlet and outlet microchannels. Fig 5.7a represents the fluid flow trajectories in a
square chamber. In the square chamber, the presence of dead volumes was identified
along with the formation of vortices, where washing of the electrode would not be
effective. Based on these observations, a design modification was incorporated, where the
chamber shape was made circular. While dead volumes were eliminated in the circular
chamber, it was observed that the fluid flow trajectory was still unevenly distributed
across the chamber area (Fig 5.7b). The angles of the inlet and outlet channels were
varied and Fig 5.7c presents the optimized design where the fluid flow trajectory was
observed to be evenly distributed across the circular chamber. Also, the velocity field
and pressure were found to be evenly distributed in the circular chamber. The maximum
Reynolds number was computed to be ~0.01 confirming laminar flow in the
microchannels.
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Fig 5.7 Results of CFD simulation in (a) square chamber; (b) circular chamber and (c)
circular chamber with inlet and outlet channels are modified position.
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5.4 LTCC Microfluidic design
Based on the outcome of the CFD simulation, the optimized design of the microfluidic
system is presented in Fig 5.8. The cross sectional schematic (Fig 5.8a) of the
microfluidic system depicts the assay chamber, microchannels and the microfabricated
sensor chip. The microfluidic chip is designed using three layers of green tape, the design
patterns of which are presented in Fig 5.8b. The bottom most layer (i) defines the reaction
chamber that interfaces with the sensor chip using a rubber O-ring. The middle layer (ii)
defines the inlet and outlet microchannels for sample/buffer introduction and waste
removal respectively. The top most layer (iii) provides the cover to the microchannels
and ports for incorporating fluidic connectors. A blowout illustration of the three-layer
LTCC microfluidic manifold with the sensor chip is presented in Fig 5.8c.

Fig 5.8 Schematic illustration of the LTCC based microfluidic system; (b) The threelayer design of the LTCC microfluidic manifold; (c) A 3D blow out of the microfluidic
chip and its integration with the sensor chip.
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5.4.1 Fabrication of LTCC microfluidic chip
For fabrication of the LTCC microfluidic manifold, LTCC green tapes (DuPont 951)
were purchased from DuPont. The green tapes were patterned using a computer
controller 10.6µm CO2 laser (Universal Laser Systems) having a spot size of 50µm. The
patterned LTCC layers were sequentially aligned using an aligning fixture that was built
in-house (Fig 5.9a). The LTCC stack is then laminated using an isostatic hot press (PHITulip) at 150ºC for 15 minutes at a pressure of 3000psi. Post-lamination, the LTCC
structure was co-fired in an oxygen rich programmable furnace by carefully ramping the
temperature up to 850ºC (Fig 5.9b). Fluidic connectors made from polydimethylsiloxane
(PDMS) (Dow Corning) were attached to the inlet and outlet ports of the microfluidic
chip and tygon tubing was used to introduce the fluids from a programmable 2-syringe
pump network (New Era Pumps). A two-piece acrylic fixture designed and fabricated inhouse was used to integrate the microfluidic manifold with the disposable sensor chip. A
rubber O-ring was used to provide a leak-free interface between the sensor chip and the
assay chamber.

Fig 5.9 Picture of the aligning fixture with LTCC tapes being aligned prior to lamination;
(b) The temperature ramping profile for the sintering process.
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Fig 5.10a presents a picture of the fabricated LTCC microfluidic manifold with
connectors and tubing attached. During the lamination stage, no sacrificial material was
used to fill the channels to prevent channel sagging[20]. Instead, a sequential lamination
process[21], where every layer was sequentially added during the lamination process,
was used to obtain sagging and delamination free microchannels. Fig 5.10b presents a
cross sectional image of the microchannel. The trapezoidal shape of the microchannel
cross section is typical of microchannels fabricated using LTCC[21, 22] and results from
the excessive burning on only one side of the soft LTCC tapes during laser patterning.
The thickness of each individual layer was measured to be 150±5 µm after firing. Due to
the trapezoidal cross-section, the width of the channel varied from 100±5 µm at the top to
150±5 µm at the base of the microchannel.

Fig 5.10 (a) The LTCC microfluidic manifold; (b) Cross sectional microscopic image of
the LTCC microchannel.
5.4.2 Fluidic Characterization in LTCC Microfluidic Chip
For characterizing the fluid flow in the assay chamber, a modified design was
utilized, where a glass window was incorporated at the top and bottom of assay chamber
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to visualize the flow of the fluids entering and exiting the assay chamber. Fig 5.11a
presents a schematic of the LTCC-glass chip used for fluid flow characterization. Pawel
et al have previously demonstrated the process of incorporating glass windows into
LTCC structures [23]. Microscope glass cover slips were sandwiched between LTCC
layers post-lamination. During the co-firing process, between 650-750°C, glass softens
and bonds to the adjacent LTCC layers, however, the surface tension forces of molten
glass assist in maintaining the structure of the glass sheet to accommodate the shrinking
of the LTCC structure. Post-sintering clear glass windows were obtained (Fig 5.11b) with
no signs of cracking or distortion. To observe the trajectory of fluid flow and to
determine the washing efficiency, red color dye solution was used to simulate the sample
(contrast) and deionized water (DI) water was used to simulate the washing buffer.
In Fig 5.11c is presented the snapshots of fluid flow in the microfluidic assay
chamber. Fig 5.11c(i) to Fig 5.11c(v) presents the introduction of the sample into the
assay chamber and Fig 5.11c(vi) to Fig 5.11c(x), the washing of the chamber is
demonstrated. It can be observed that the trajectory of fluid flow is in accordance with the
results obtained from the simulation (Fig 5.7c). Also, the designed flow rate (10µl/min)
and volume (30µl) of the buffer provided the required washing efficiency.
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Fig 5.11 (a) Schematic of the LTCC microfluidic chip used for fluid flow
characterization; (b) Picture of the glass window integrated into the LTCC chip; (c)
Microscopic images of the fluid flow profiles in the assay chamber.
To preferentially select the fluid going into the inlet microchannel, a solenoid
three-way valve (The Lee Company) was used. The valve maintains a default path where
the fluid flows into valves primary inlet ports and exits through a common outlet port
(Fig 5.12a) and upon activation of the valve, fluid flow switches to a secondary inlet port
while exiting through the same common outlet (Fig 5.12b). The valve requires a
threshold current of 150mA and 5V to actuate. Fig 5.12c presents the schematic of the
electrical circuit used to actuate the solenoid valve. The circuit uses an opto-isolator to
separate the grounds within the same circuit. The opto-isolator provides the necessary
current to trigger the transistor to a state of saturation; where in the transistor is used as a
switch. The circuit provides to the valve 4.87 V and 158 mA, which was found to be
sufficient to activate the valve.
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Fig 5.12 (a,b) Schematic of the operation of the fluidic valve; (c) Schematic of the
electronic circuit designed for the activation of the fluidic valve.
The functioning of the fluidic valve was also characterized using two contrast
dyes and the functioning of the fluidic valve was verified and is presented in Fig 5.13. In
this three-way valve, the common outlet is in the center with each of the two inlets on
either side. Under normal conditions (Fig 5.13a), the left input (blue) is open, and the
actuation of the valve (Fig 5.13b) switches the flow to the right input (red). A two-piece
acrylic fixture designed to house the microfluidic system was fabricated in-house. Fig
5.13c presents the picture of the testing fixture with the microfluidic chip, the fluid
control valve and the disposable sensor chip. All the electrochemical assays as described
in Chapter IV were repeated successfully in the fully automated microfluidic system with
negligible change in the baselines of the electrochemical response.
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5.5 Conclusion
In this chapter, the efforts to develop a low-cost microfluidic system for
integrating the developed electrochemical immunosensing platform and the automation
of the immunosensing assay are presented. The microfluidic system is developed using
LTCC technology, as an alternative to conventional microfluidic systems based on
silicon, glass and polymer. For the first time, the non-specific adsorption (NSA) of a
biomolecule (Cortisol) on LTCC surface has been characterized as part of the
microfluidic system design and development. A CFD approach has been used to optimize
the microfluidic geometry with regards to the immunoassay fluidic protocol.

The

optimized design, fabrication and empirical fluidic characterization of LTCC based
microfluidic system is presented. The DTSP-SAM based electrochemical immunosensor
is successfully integrated into the microfluidic manifold and the immunosensing assay
has been successfully automated for the detection of cortisol.
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CHAPTER VI
Summary and Future Direction
6.1 Summary
In summary, this dissertation has detailed the development of a label-free,
electrochemical immunosensing platform integrated into a low-cost microfluidic system
for the sensitive, selective and accurate detection of cortisol, a steroid hormone co-related
with many physiological disorders. Abnormal levels of cortisol is indicative of conditions
such as Cushing’s syndrome, Addison’s disease, adrenal insufficiencies and more
recently post-traumatic stress disorder (PTSD). Electrochemical detection of immunocomplex formation has been utilized for the sensitive detection of Cortisol using AntiCortisol antibodies immobilized on sensing electrodes. Electrochemical detection
techniques such as cyclic voltammetry (CV) and electrochemical impedance
spectroscopy (EIS) have been utilized for the characterization and sensing of the labelfree detection of Cortisol. The utilization of nanomaterials as the immobilizing matrix for
Anti-cortisol antibodies that leads to improved sensor response has been explored.
The first research activity undertaken was to establish an immunosensing platform for
the electrochemical detection of cortisol. A nanostructured immunosensing platform
based on a hybrid nanocomposite film of core-shell Ag@AgO nanoparticles and
Polyanaline (PANI) has been synthesized using electrophoretic deposition (EPD) onto Au
substrate. The core-shell Ag@AgO nanoparticle (~5 nm) has successfully been
embedded in PANI backbone to make a highly electro-active Ag@AgO-PANI
nanocomposite. For the first time, the electrophoretically deposited nanomaterial was
utilized for the immobilization of monoclonal Anti-Cab to fabricate a label-free and
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mediator free electrochemical immunosensor for cortisol detection. Results of
electrochemical characterization suggest that Ag@AgO nanoparticle act as doping agents
for PANI and result in the increase charge density and stabilize electrochemical behavior,
resulting in enhanced charge transfer from redox moieties to electrode. This increased
electro-active platform with nano-porous morphology and functionality provides a
friendly environment to immobilize Anti-Cab. The immunosensor was tested as a function
of cortisol concentrations in phosphate buffer saline (PBS) using cyclic voltammetry and
found to exhibit a detection limit of 0.64pg mL-1 (estimated using 3σ formula), a linear
range from 1pM to 1μM , with a sensitivity of 66μA/M.
The ultimate goal of this research was to develop a point-of-care immunosensing
platform for the detection of cortisol. Hence next logical step was to integrate the
immunosensing platform onto a micromachined co-planar electrode set-up. The
developed Ag@AgO-PANI based immunosensor was unable to be successfully
integrated onto microfabricated electrodes due to a high degree of non-specific
electrophoretic deposition of the hybrid nanocomposite onto the base substrate (Glass)
leading to electrical shorting of the fabricated electrodes. To overcome challenges related
to system integration, an alternate strategy, involving the use of self-assembled
monolayer of DTSP as the nanostructured matrix for the immobilization of anti-Cortisol
antibodies was explored. The DTSP-SAM was modified onto microfabricated
interdigitated microelectrodes (µIDE). Electrochemical characterization of the DTSPSAM modification and fabrication of the immunoelectrode is presented. The
immunosensor was tested as a function of cortisol concentrations in phosphate buffer
saline (PBS) using cyclic voltammetry and found to exhibit a detection limit of 10pM, a
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linear range from 10pM to 200nM, with a sensitivity of 20.7µA/M. The next research
activity planned was to automate the electrochemical immunoassay as a step towards
realizing a fully automated point-of-care cortisol sensor. The microfluidic system is
developed using LTCC technology, as an alternative to conventional microfluidic
systems based on silicon, glass and polymer. For the first time, the non-specific
adsorption (NSA) of a biomolecule (Cortisol) on LTCC surface has been characterized as
part of the microfluidic system design and development. A CFD approach has been used
to optimize the microfluidic geometry with regards to the immunoassay fluidic protocol.
The optimized design, fabrication and empirical fluidic characterization of LTCC based
microfluidic system is presented. The DTSP-SAM based electrochemical immunosensor
is successfully integrated into the microfluidic manifold and the immunosensing assay
has been successfully automated for the detection of cortisol. The developed sensor holds
potential for application in sensing of cortisol in real-time and at point-of-care. The future
prospects is presented in the next section.

6.2 Future Direction
The future direction for the developed microfluidic cortisol sensing system is envisioned
in two directions, a brief description of which is provided here.
1. Wearable sensors for monitoring of stress related disorders
Lifestyle related health issues have gained attention and focus over the last
decade due to increasing effects of day to day activities on general health. One
such serious issue is psychological stress experienced by individuals on a daily
basis. The human body reacts to stress in different ways, of which, the release of
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hormones and neurotransmitters is a typical response. Prolonged exposure to
stress leads to the activation of signaling pathways from the brain that leads to
release of cortisol from the adrenal cortex. Cortisol secretion levels have been
correlated to stress levels in patients suffering from stress disorders such as
posttraumatic stress disorder (PTSD), insomnia and burnouts. PTSD affects about
24 million people in the Unites States alone with 30% of combat veterans having
been reported with PTSD. The sensing platform reported in this dissertation for
detection of cortisol has the potential to be integrated into a wearable system for
online and continuous monitoring of cortisol levels as a function of one’s
environment. This Cortisol sensor, coupled with a continuous biofluid harvesting
system, could allow a continuous readout of Cortisol levels in the ambulatory
setting, providing real-time information on cortisol secretion values when a
patient is subjected to psychological stress as a resulting of triggers from the
surroundings and situations. The information arising from the data could be used
to understand behavioral patterns and also could be used to create personalized
and targeted medications for stress related disorders. The continuous monitoring
system may also provide information on the 24-hour diurnal cortisol at the night
time minimum value and can identify the precise point in the sleep cycle at which
Cortisol begins its morning cycle. It could provide easy access to the postawakening daily peak of Cortisol production as well.

2. Disposable Microfluidic Cortisol Sensor for point-of-care diagnostics
A novel microfluidic system design has been envisioned that incorporates the
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